{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:21Z","timestamp":1792173501548,"version":"4.4.0"},"publisher-location":"Singapore","reference-count":315,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811377082","type":"print"},{"value":"9789811377099","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-7709-9_15","type":"book-chapter","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:57:22Z","timestamp":1567537042000},"page":"345-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Fibrinolytic Enzymes for Thrombolytic Therapy"],"prefix":"10.1007","author":[{"given":"Swaroop S.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhameed","family":"Sabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,4]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/bit.260260502","volume":"26","author":"AF Abdel-Fattah","year":"1984","unstructured":"Abdel-Fattah AF, Ismail AM (1984) Purification and some properties of pure Cochliobolus lunatus fibrinolytic enzyme. Biotechnol Bioeng 26:407\u2013411","journal-title":"Biotechnol Bioeng"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1055\/s-0038-1649569","volume":"70","author":"G Agnelli","year":"1993","unstructured":"Agnelli G, Pascucci C, Nenci GG, Mele A, Burgi R, Heim J (1993) Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935). Thromb Haemost 70:294\u2013300","journal-title":"Thromb Haemost"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.procbio.2009.06.024","volume":"44","author":"R Agrebi","year":"2009","unstructured":"Agrebi R, Haddar A, Hmidet N, Jellouli K, Manni L, Nasri M (2009) BSF1 fibrinolytic enzyme from a marine bacterium Bacillus subtilis A26: purification, biochemical and molecular characterization. Process Biochem 44:1252\u20131259","journal-title":"Process Biochem"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12010-009-8800-z","volume":"162","author":"R Agrebi","year":"2010","unstructured":"Agrebi R, Hmidet N, Hajji M, Ktari N, Haddar A, Fakhfakh-Zouari N, Nasri M (2010) Fibrinolytic serine protease isolation from Bacillus amyloliquefaciens An6 grown on Mirabilis jalapa tuber powders. Appl Biochem Biotechnol 162:75\u201388","journal-title":"Appl Biochem Biotechnol"},{"key":"15_CR5","volume":"3","author":"MI Aguilar","year":"2005","unstructured":"Aguilar MI, Hart R (2005) Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 3:CD001927","journal-title":"Cochrane Database Syst Rev"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.thromres.2004.01.005","volume":"112","author":"MY Ahn","year":"2003","unstructured":"Ahn MY, Hahn BS, Ryu KS, Kim JW, Kim I, Kim YS (2003) Purification and characterization of a serine protease with fibrinolytic activity from the dung beetles, Catharsius molossus. Thromb Res 112:339\u2013347","journal-title":"Thromb Res"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1517\/17425255.3.4.609","volume":"3","author":"I Ahrens","year":"2007","unstructured":"Ahrens I, Smith BK, Bode C, Peter K (2007) Direct thrombin inhibition with bivalirudin as an antithrombotic strategy in general and interventional cardiology. Expert Opin Drug Metab Toxicol 3:609\u2013620","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(15)00047-2","volume":"14","author":"GW Albers","year":"2015","unstructured":"Albers GW, von Kummer R, Truelsen T, Jensen JKS, Ravn GM, Gronning BA, Chabriat H, Chang KC, Davalos AE, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A, DIAS-3 Investigators (2015) Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet Neurol 14:575\u2013584","journal-title":"Lancet Neurol"},{"key":"15_CR9","volume":"2014","author":"MR Ali","year":"2014","unstructured":"Ali MR, Salim Hossain M, Islam MA, Saiful Islam Arman M, Sarwar Raju G, Dasgupta P, Noshin TF (2014) Aspect of thrombolytic therapy: a review. Sci World J 2014:586510","journal-title":"Sci World J"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1172\/JCI103885","volume":"38","author":"N Alkjaersig","year":"1959","unstructured":"Alkjaersig N, Fletcher AP, Sherry S (1959) The mechanism of clot dissolution by plasmin. J Clin Invest 38:1086\u20131095","journal-title":"J Clin Invest"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"160S","DOI":"10.1378\/chest.08-0670","volume":"133","author":"J Ansell","year":"2008","unstructured":"Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133:160S\u2013198S","journal-title":"Chest"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1016\/S0021-9258(18)61211-6","volume":"262","author":"E Appella","year":"1987","unstructured":"Appella E, Robinson EA, Ullrich SJ, Stoppelli MP, Corti A, Cassani G, Blasi F (1987) The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. J Biol Chem 262:4437\u20134440","journal-title":"J Biol Chem"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S0002-8703(00)90013-9","volume":"139","author":"PW Armstrong","year":"2000","unstructured":"Armstrong PW, Burton JR, Palisaitis D, Thompson CR, Van de Werf F, Rose B, Collen D, Teo KK (2000) Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS). Am Heart J 139:820\u2013823","journal-title":"Am Heart J"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0002-8703(03)00312-0","volume":"146","author":"PW Armstrong","year":"2003","unstructured":"Armstrong PW, Burton J, Pakola S, Molhoek PG, Betriu A, Tendera M, Bode C, Adgey AA, Bar F, Vahanian A, Van de Werf F, CAPTORS II Investigators (2003) Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II). Am Heart J 146:484\u2013488","journal-title":"Am Heart J"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/3-540-36028-X_1","volume-title":"The vascular endothelium II. Handbook of experimental pharmacology","author":"J Arnout","year":"2006","unstructured":"Arnout J, Hoylaerts MF, Lijnen HR (2006) Haemostasis. In: Moncada S, Higgs A (eds) The vascular endothelium II. Handbook of experimental pharmacology, vol 176\/II. Springer, Berlin, pp 1\u201341"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0009-8981(77)90070-5","volume":"78","author":"M Aubry","year":"1977","unstructured":"Aubry M, Bieth J (1977) Kinetics of the inactivation of human and bovine trypsins and chymotrypsins by \u03b11-proteinase inhibitor and of their reactivation by \u03b12-macroglobulin. Clin Chim Acta 78:371\u2013380","journal-title":"Clin Chim Acta"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9149(97)89274-0","volume":"79","author":"FW Bar","year":"1997","unstructured":"Bar FW, Meyer J, Vermeer F, Michels R, Charbonnier B, Haerten K, Spiecker M, Macaya C, Hanssen M, Heras M, Boland JP, Morice MC, Dunn FG, Uebis R, Hamm C, Ayzenberg O, Strupp G, Withagen AJ, Klein W, Windeler J, Hopkins G, Barth H, von Fisenne MJ, SESAM Study Group (1997) Comparison of saruplase and alteplase in acute myocardial infarction. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction. Am J Cardiol 79:727\u2013732","journal-title":"Am J Cardiol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1023\/A:1012343718772","volume":"70","author":"BP Batomunkueva","year":"2001","unstructured":"Batomunkueva BP, Egorov NS (2001) Isolation, purification, and resolution of the extracellular proteinase complex of Aspergillus ochraceus 513 with fibrinolytic and anticoagulant activities. Microbiology 70:519\u2013523","journal-title":"Microbiology"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1182\/asheducation-2006.1.450","volume":"1","author":"KA Bauer","year":"2006","unstructured":"Bauer KA (2006) New anticoagulants. Hematology 1:450\u2013456","journal-title":"Hematology"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.5352\/JLS.2005.15.6.987","volume":"15","author":"H Bek","year":"2005","unstructured":"Bek H, Hak-Seob L, Kyung Kae C, Choi Y, Byung Tae C, Min-Jeong S, Ji-Eun K, Eun-Ju R, Man Kyu H, Joo WH, Young Kee J (2005) Characterization of a novel fibrinolytic enzyme produced from Bacillus subtilis BK-17. J Life Sci 15:987\u2013993","journal-title":"J Life Sci"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1172\/JCI107246","volume":"52","author":"MB Bernik","year":"1973","unstructured":"Bernik MB (1973) Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition. J Clin Invest 52:823\u2013834","journal-title":"J Clin Invest"},{"key":"15_CR22","first-page":"650","volume":"70","author":"MB Bernik","year":"1967","unstructured":"Bernik MB, Kwaan HC (1967) Origin of fibrinolytic activity in cultures of the human kidney. J Lab Clin Med 70:650\u2013661","journal-title":"J Lab Clin Med"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1172\/JCI106140","volume":"48","author":"MB Bernik","year":"1969","unstructured":"Bernik MB, Kwaan HC (1969) Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. J Clin Invest 48:1740\u20131753","journal-title":"J Clin Invest"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijsu.2013.01.010","volume":"11","author":"S Bhagat","year":"2013","unstructured":"Bhagat S, Agarwal M, Roy V (2013) Serratiopeptidase: a systematic review of the existing evidence. Int J Surg 11:209\u2013217","journal-title":"Int J Surg"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1177\/10760296990050S111","volume":"5","author":"RL Bick","year":"1999","unstructured":"Bick RL, Fareed J (1999) Low molecular weight heparins: differences and similarities in approved preparations in the United States. Clin Appl Thromb Hemost 5:S63\u2013S66","journal-title":"Clin Appl Thromb Hemost"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"25596","DOI":"10.1074\/jbc.270.43.25596","volume":"270","author":"P Bringmann","year":"1995","unstructured":"Bringmann P, Gruber D, Liese A, Toschi L, Kratzschmar J, Schleuning WD, Donner P (1995) Structural features mediating fibrin selectivity of vampire bat plasminogen activators. J Biol Chem 270:25596\u201325603","journal-title":"J Biol Chem"},{"key":"15_CR03","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.CIR.95.2.351","volume":"95","author":"CP Cannon","year":"1997","unstructured":"Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy RP, Love TW, Braunwald E (1997) TNK-tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial. Circulation 95:351\u2013356","journal-title":"Circulation"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1161\/01.CIR.98.25.2805","volume":"98","author":"CP Cannon","year":"1998","unstructured":"Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E (1998) Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation 98:2805\u20132814","journal-title":"Circulation"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.2165\/00003495-200262050-00008","volume":"62","author":"CI Carswell","year":"2002","unstructured":"Carswell CI, Plosker GL (2002) Bivalirudin: a review of its potential place in the management of acute coronary syndromes. Drugs 62:841\u2013870","journal-title":"Drugs"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1016\/j.biortech.2010.02.048","volume":"101","author":"WS Cha","year":"2010","unstructured":"Cha WS, Park SS, Kim SJ, Choi D (2010) Biochemical and enzymatic properties of a fibrinolytic enzyme from Pleurotus eryngii cultivated under solid-state conditions using corn cob. Bioresour Technol 101:6475\u20136481","journal-title":"Bioresour Technol"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1148\/radiol.2442061316","volume":"244","author":"F Chen","year":"2007","unstructured":"Chen F, Suzuki Y, Nagai N, Sun X, Wang H, Yu J, Marchal G, Ni Y (2007) Microplasmin and tissue plasminogen activator: comparison of therapeutic effects in rat stroke model at multiparametric MR imaging. Radiology 244:429\u2013438","journal-title":"Radiology"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.eye.6702931","volume":"22","author":"W Chen","year":"2008","unstructured":"Chen W, Huang X, Ma XW, Mo W, Wang WJ, Song HY (2008) Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator. Eye 22:300\u2013307","journal-title":"Eye"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4014\/jmb.1503.03015","volume":"25","author":"G Cheng","year":"2015","unstructured":"Cheng G, He L, Sun Z, Cui Z, Du Y, Kong Y (2015) Purification and biochemical characterization of a novel fibrinolytic enzyme from Streptomyces sp. P3. J Microbiol Biotechnol 25:1449\u20131459","journal-title":"J Microbiol Biotechnol"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1046\/j.1365-2672.2000.00831.x","volume":"31","author":"RR Chitte","year":"2000","unstructured":"Chitte RR, Dey S (2000) Potent fibrinolytic enzyme from a thermophilic Streptomyces megasporus strain SD5. Lett Appl Microbiol 31:405\u2013410","journal-title":"Lett Appl Microbiol"},{"key":"15_CR34","first-page":"199","volume":"37","author":"IH Cho","year":"2004","unstructured":"Cho IH, Choi ES, Lim HG, Lee HH (2004) Purification and characterization of six fibrinolytic serine-proteases from earthworm Lumbricus rubellus. J Biochem Mol Biol 37:199\u2013205","journal-title":"J Biochem Mol Biol"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2307\/3761514","volume":"92","author":"HS Choi","year":"2000","unstructured":"Choi HS, Sa YS (2000) Fibrinolytic and antithrombotic protease from Ganoderma lucidum. Mycologia 92:545\u2013552","journal-title":"Mycologia"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1271\/bbb.65.781","volume":"65","author":"HS Choi","year":"2001","unstructured":"Choi HS, Sa YS (2001) Fibrinolytic and antithrombotic protease from Spirodela polyrhiza. Biosci Biotechnol Biochem 65:781\u2013786","journal-title":"Biosci Biotechnol Biochem"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2307\/3761226","volume":"90","author":"HS Choi","year":"1998","unstructured":"Choi HS, Shin HH (1998) Purification and partial characterization of a fibrinolytic protease in Pleurotus ostreatus. Mycologia 90:674\u2013679","journal-title":"Mycologia"},{"key":"15_CR38","first-page":"72","volume":"15","author":"NS Choi","year":"2005","unstructured":"Choi NS, Yoo KH, Hahm JH, Yoon KS, Hyun BH, Maeng PJ, Kim SH (2005) Purification and characterization of a new peptidase, bacillopeptidase DJ-2, having fibrinolytic activity: produced by Bacillus sp. DJ-2 from Doen-Jang. J Microbiol Biotechnol 15:72\u201379","journal-title":"J Microbiol Biotechnol"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1085\/jgp.28.4.363","volume":"28","author":"LR Christensen","year":"1945","unstructured":"Christensen LR (1945) Streptococcal fibrinolysis: a proteolytic reaction due to a serum enzyme activated by streptococcal fibrinolysin. J Gen Physiol 28:363\u2013383","journal-title":"J Gen Physiol"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1085\/jgp.30.6.465","volume":"30","author":"LR Christensen","year":"1947","unstructured":"Christensen LR (1947) Protamine purification of streptokinase and effect of pH and temperature on reversible inactivation. J Gen Physiol 30:465\u2013473","journal-title":"J Gen Physiol"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1152\/jappl.1953.6.3.143","volume":"6","author":"EE Cliffton","year":"1953","unstructured":"Cliffton EE, Cannamela DA, Grossi C (1953) In vivo studies of human plasmin. Intravenous injection in dogs and rabbits. J Appl Physiol 6:143\u2013150","journal-title":"J Appl Physiol"},{"key":"15_CR42","first-page":"33","volume":"36","author":"M Cohen","year":"1999","unstructured":"Cohen M (1999) Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins in acute coronary syndromes. Semin Hematol 36:33\u201336","journal-title":"Semin Hematol"},{"key":"15_CR04","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood.V71.1.216.216","volume":"71","author":"D Collen","year":"1988","unstructured":"Collen D, Stassen JM, Larsen G (1988) Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits. Blood 71:216\u2013219","journal-title":"Blood"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1161\/01.CIR.87.6.1850","volume":"87","author":"D Collen","year":"1993","unstructured":"Collen D, Van de Werf F (1993) Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarction. Circulation 87:1850\u20131853","journal-title":"Circulation"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.CIR.94.2.207","volume":"94","author":"D Collen","year":"1996","unstructured":"Collen D, Moreau H, Stockx L, Vanderschueren S (1996) Recombinant staphylokinase variants with altered immunoreactivity: II: thrombolytic properties and antibody induction. Circulation 94:207\u2013216","journal-title":"Circulation"},{"key":"15_CR45","first-page":"95","volume":"4","author":"LL Craven","year":"1950","unstructured":"Craven LL (1950) Acetylsalicylic acid, possible preventive of coronary thrombosis. Ann West Med Surg 4:95","journal-title":"Ann West Med Surg"},{"key":"15_CR46","first-page":"38","volume":"75","author":"LL Craven","year":"1953","unstructured":"Craven LL (1953) Experiences with aspirin (acetylsalicylic acid) in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J 75:38\u201344","journal-title":"Miss Valley Med J"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11274-007-9497-1","volume":"24","author":"L Cui","year":"2008","unstructured":"Cui L, Dong MS, Chen XH, Jiang M, Lv X, Yan G (2008) A novel fibrinolytic enzyme from Cordyceps militaris, a Chinese traditional medicinal mushroom. World J Microbiol Biotechnol 24:483\u2013489","journal-title":"World J Microbiol Biotechnol"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2296-5-15","volume":"5","author":"GC Dantas","year":"2004","unstructured":"Dantas GC, Thompson BV, Manson JA, Tracy CS, Upshur REG (2004) Patients\u2019 perspectives on taking warfarin: qualitative study in family practice. BMC Fam Pract 5:15","journal-title":"BMC Fam Pract"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/S0021-9258(18)93901-3","volume":"239","author":"MC Davies","year":"1964","unstructured":"Davies MC, Englert ME, Derenzo EC (1964) Interaction of streptokinase and human plasminogen. I. Combining of streptokinase and plasminogen observed in the ultracentrifuge under a variety of experimental conditions. J Biol Chem 239:2651\u20132656","journal-title":"J Biol Chem"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0021-9258(18)96306-4","volume":"242","author":"EC De Renzo","year":"1967","unstructured":"De Renzo EC, Siiteri PK, Hutchings BL, Bell PH (1967) Preparation and certain properties of highly purified streptokinase. J Biol Chem 242:533\u2013542","journal-title":"J Biol Chem"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1167\/iovs.08-2185","volume":"50","author":"MD de Smet","year":"2009","unstructured":"de Smet MD, Valmaggia C, Zarranz-Ventura J, Willekens B (2009) Microplasmin: ex vivo characterization of its activity in porcine vitreous. Invest Ophthalmol Vis Sci 50:814\u2013819","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1016\/j.biortech.2008.03.018","volume":"99","author":"V Deepak","year":"2008","unstructured":"Deepak V, Kalishwaralal K, Ramkumarpandian S, Babu SV, Senthilkumar SR, Sangiliyandi G (2008) Optimization of media composition for Nattokinase production by Bacillus subtilis using response surface methodology. Bioresour Technol 99:8170\u20138174","journal-title":"Bioresour Technol"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.enzmictec.2010.07.004","volume":"47","author":"V Deepak","year":"2010","unstructured":"Deepak V, Ilangovan S, Sampathkumar MV, Victoria MJ, Pasha SPBS, Pandian SBRK, Gurunathan S (2010) Medium optimization and immobilization of purified fibrinolytic URAK from Bacillus cereus NK1 on PHB nanoparticles. Enzym Microb Technol 47:297\u2013304","journal-title":"Enzym Microb Technol"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1517\/14712598.6.12.1361","volume":"6","author":"SR Deitcher","year":"2006","unstructured":"Deitcher SR, Funk WD, Buchanan J, Liu S, Levy MD, Toombs CF (2006) Alfimeprase: a novel recombinant direct-acting fibrinolytic. Expert Opin Biol Ther 6:1361\u20131369","journal-title":"Expert Opin Biol Ther"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/01.STR.29.1.4","volume":"29","author":"GJ del Zoppo","year":"1998","unstructured":"del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M (1998) PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 29:4\u201311","journal-title":"Stroke"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1161\/01.CIR.98.20.2117","volume":"98","author":"P den Heijer","year":"1998","unstructured":"den Heijer P, Vermeer F, Ambrosioni E, Sadowski Z, L\u00f3pez Send\u00f3n JL, von Essen R, Beaufils P, Thadani U, Adgey J, Pierard L, Brinker J, Davies RF, Smalling RW, Wallentin L, Caspi A, Pangerl A, Trickett L, Hauck C, Henry D, Chew P (1998) Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase. Circulation 98:2117\u20132125","journal-title":"Circulation"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/BF00127431","volume":"17","author":"SA El-Aassar","year":"1995","unstructured":"El-Aassar SA (1995) Production and properties of fibrinolytic enzyme in solid state cultures of Fusarium pallidoroseum. Biotechnol Lett 17:943\u2013948","journal-title":"Biotechnol Lett"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00170564","volume":"33","author":"SA El-Aassar","year":"1990","unstructured":"El-Aassar SA, El-Badry HM, Abdel-Fattah AF (1990) The biosynthesis of proteases with fibrinolytic activity in immobilized cultures of Penicillium chrysogenum H9. Appl Microbiol Biotechnol 33:26\u201330","journal-title":"Appl Microbiol Biotechnol"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12906-015-0643-2","volume":"15","author":"TB Emran","year":"2015","unstructured":"Emran TB, Rahman MA, Uddin MMN, Rahman MM, Uddin MZ, Dash R, Layzu C (2015) Effects of organic extracts and their different fractions of five Bangladeshi plants on in vitro thrombolysis. BMC Complement Altern Med 15:128","journal-title":"BMC Complement Altern Med"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1538-7836.2005.01657.x","volume":"4","author":"BI Eriksson","year":"2006","unstructured":"Eriksson BI, Borris L, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, K\u00e4lebo P, ODIXa-HIP Study Investigators (2006) Oral, direct factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost 4:121\u2013128","journal-title":"J Thromb Haemost"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/MBC.0000000000000531","volume":"27","author":"ME Errasti","year":"2016","unstructured":"Errasti ME, Prospitti A, Viana CA, Gonzalez MM, Ramos MV, Rotelli AE, Caffini NO (2016) Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain. Blood Coagul Fibrinolysis 27:441\u2013449","journal-title":"Blood Coagul Fibrinolysis"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0038-1660378","volume":"19","author":"J Fareed","year":"1999","unstructured":"Fareed J, Walenga JM, Hoppensteadt D, Kaiser B, Jeske W (1999) Factor Xa inhibitors in the control of thrombogenesis. Hamostaseologie 19:55\u201362","journal-title":"Hamostaseologie"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.2042-7158.2012.01457.x","volume":"64","author":"M Flemmig","year":"2012","unstructured":"Flemmig M, Melzig MF (2012) Serine-proteases as plasminogen activators in terms of fibrinolysis. J Pharm Pharmacol 64:1025\u20131039","journal-title":"J Pharm Pharmacol"},{"key":"15_CR64","first-page":"287","volume":"71","author":"AP Fletcher","year":"1958","unstructured":"Fletcher AP, Alkjaersig N, Smyrniotis FE, Sherry S (1958) The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Phys 71:287\u2013296","journal-title":"Trans Assoc Am Phys"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1172\/JCI103886","volume":"38","author":"AP Fletcher","year":"1959","unstructured":"Fletcher AP, Alkjaersig N, Sherry S (1959a) The maintenance of a sustained thrombolytic state in man. I. Induction and effects. J Clin Invest 38:1096\u20131110","journal-title":"J Clin Invest"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI103887","volume":"38","author":"AP Fletcher","year":"1959","unstructured":"Fletcher AP, Sherry S, Alkjaersig N, Smyrniotis FE, Jick S (1959b) The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 38:1111\u20131119","journal-title":"J Clin Invest"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1021\/bi00244a035","volume":"30","author":"V Fleury","year":"1991","unstructured":"Fleury V, Angles-Cano E (1991) Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 30:7630\u20137638","journal-title":"Biochemistry"},{"key":"15_CR68","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.phytochem.2010.02.009","volume":"71","author":"KC Fonseca","year":"2010","unstructured":"Fonseca KC, Morais NCG, Queiroz MR, Silva MC, Gomes MS, Costa JO, Mamede CCN, Torres FS, Penha-Silva N, Beletti ME, Canabrava HAN, Oliveira F (2010) Purification and biochemical characterization of Eumiliin from Euphorbia milii var. hislopii latex. Phytochemistry 71:708\u2013715","journal-title":"Phytochemistry"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.thromres.2008.01.007","volume":"122","author":"J Fu","year":"2008","unstructured":"Fu J, Ren J, Zou L, Bian G, Li R, Lu Q (2008) The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis. Thromb Res 122:683\u2013690","journal-title":"Thromb Res"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1006\/bbrc.1993.2624","volume":"197","author":"M Fujita","year":"1993","unstructured":"Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S (1993) Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun 197:1340\u20131347","journal-title":"Biochem Biophys Res Commun"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1248\/bpb.18.1387","volume":"18","author":"M Fujita","year":"1995","unstructured":"Fujita M, Hong K, Ito Y, Fujii R, Kariya K, Nishimuro S (1995a) Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol Pharm Bull 18:1387\u20131391","journal-title":"Biol Pharm Bull"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1248\/bpb.18.1194","volume":"18","author":"M Fujita","year":"1995","unstructured":"Fujita M, Hong K, Ito Y, Misawa S, Takeuchi N, Kariya K, Nishimuro S (1995b) Transport of nattokinase across the rat intestinal tract. Biol Pharm Bull 18:1194\u20131196","journal-title":"Biol Pharm Bull"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0268-9499(95)80005-0","volume":"9","author":"M Fujita","year":"1995","unstructured":"Fujita M, Ito Y, Hong K, Nishimuro S (1995c) Characterization of nattokinase-degraded products from human fibrinogen or cross-linked fibrin. Fibrinolysis 9:157\u2013164","journal-title":"Fibrinolysis"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"282","author":"A Furlan","year":"1999","unstructured":"Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003\u20132011","journal-title":"JAMA"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pep.2005.04.005","volume":"42","author":"T Ge","year":"2005","unstructured":"Ge T, Sun ZJ, Fu SH, Liang GD (2005) Cloning of thrombolytic enzyme (lumbrokinase) from earthworm and its expression in the yeast Pichia pastoris. Protein Expr Purif 42:20\u201328","journal-title":"Protein Expr Purif"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/162732a0","volume":"162","author":"EB Gerheim","year":"1948","unstructured":"Gerheim EB (1948) Staphylococcal coagulation and fibrinolysis. Nature 162:732","journal-title":"Nature"},{"key":"15_CR77","first-page":"314","volume":"269","author":"D Gerlach","year":"1988","unstructured":"Gerlach D, Kraft R, Behnke D (1988) Purification and characterization of the bacterial plasminogen activator staphylokinase secreted by a recombinant Bacillus subtilis. Zentralbl Bakteriol Mikrobiol Hyg A 269:314\u2013322","journal-title":"Zentralbl Bakteriol Mikrobiol Hyg A"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/bmj.316.7127.280","volume":"316","author":"AH Gershlick","year":"1998","unstructured":"Gershlick AH, More RS (1998) Treatment of myocardial infarction. BMJ 316:280\u2013284","journal-title":"BMJ"},{"key":"15_CR79","first-page":"397","volume":"327","author":"GISSI","year":"1986","unstructured":"GISSI (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per la Sperimentazione della Streptochinasi nell\u2019Infarto Miocardico (GISSI). Lancet 327:397\u2013402","journal-title":"Lancet"},{"key":"15_CR01","first-page":"65","volume":"336","author":"GISSI-2","year":"1990","unstructured":"GISSI-2 (1990) A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo studio della Sopravvivenza nell\u2019Infarto Miocardico. Lancet 336:65\u201371","journal-title":"Lancet"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1055\/s-2001-18490","volume":"01","author":"SZ Goldhaber","year":"2001","unstructured":"Goldhaber SZ, Bounameaux H (2001) Thrombolytic therapy in pulmonary embolism. Semin Vasc Med 01:213\u2013220","journal-title":"Semin Vasc Med"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.CIR.83.2.448","volume":"83","author":"JM Gore","year":"1991","unstructured":"Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML (1991) Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction study. Thrombolysis in Myocardial Infarction, phase II, pilot and clinical trial. Circulation 83:448\u2013459","journal-title":"Circulation"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1160\/TH06-04-0197","volume":"96","author":"AHC Guimaraes","year":"2006","unstructured":"Guimaraes AHC, Barrett-Bergshoeff MM, Criscuoli M, Evangelista S, Rijken DC (2006) Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models: sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI). Thromb Haemost 96:325\u2013330","journal-title":"Thromb Haemost"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","volume":"329","author":"GUSTO Angiographic Investigators","year":"1993","unstructured":"GUSTO Angiographic Investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329:1615\u20131622","journal-title":"N Engl J Med"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJM199710163371603","volume":"337","author":"GUSTO III Investigators","year":"1997","unstructured":"GUSTO III Investigators (1997) Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III). A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 337:1118\u20131123","journal-title":"N Engl J Med"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","volume":"36","author":"W Hacke","year":"2005","unstructured":"Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A, Eliasziw M, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S, DIAS Study Group (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66\u201373","journal-title":"Stroke"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(08)70267-9","volume":"8","author":"W Hacke","year":"2009","unstructured":"Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, Kaste M, Lipka LJ, Pedraza S, Ringleb PA, Rowley HA, Schneider D, Schwamm LH, Leal JS, S\u00f6hngen M, Teal PA, Wilhelm-Ogunbiyi K, Wintermark M, Warach S (2009) Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion\u2013diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 8:141\u2013150","journal-title":"Lancet Neurol"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-0037-1619637","volume":"24","author":"J Harenberg","year":"2004","unstructured":"Harenberg J, Fenyvesi T (2004) Heparin, thrombin and factor Xa inhibitors. Hamostaseologie 24:261\u2013278","journal-title":"Hamostaseologie"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12038-011-9151-9","volume":"36","author":"WA Hassanein","year":"2011","unstructured":"Hassanein WA, Kotb E, Awny NM, El-Zawahry YA (2011) Fibrinolysis and anticoagulant potential of a metallo protease produced by Bacillus subtilis K42. J Biosci 36:773\u2013779","journal-title":"J Biosci"},{"key":"15_CR90","first-page":"2012","volume":"59","author":"JB Herrick","year":"1912","unstructured":"Herrick JB (1912) Certain clinical features of sudden obstruction of the coronary arteries. JAMA 59:2012","journal-title":"JAMA"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0268-9499(96)80007-5","volume":"10","author":"M Hildebrand","year":"1996","unstructured":"Hildebrand M, Bhargava AS, Bringmann P, Schutt A, Verhallen P (1996) Pharmacokinetics of the novel plasminogen activator Desmodus rotundus plasminogen activator in animals and extrapolation to man. Fibrinolysis 10:269\u2013276","journal-title":"Fibrinolysis"},{"key":"15_CR92","first-page":"1231","volume":"27","author":"K Hirahara","year":"1989","unstructured":"Hirahara K, Saitoh T, Terada I, Uno K, Nagai A, Kioi S, Arakawa M (1989) A case of pneumonitis due to serrapeptase. Nihon Kyobu Shikkan Gakkai Zasshi 27:1231\u20131236","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","volume":"103","author":"J Hirsh","year":"2001","unstructured":"Hirsh J, Anand SS, Halperin JL, Fuster V (2001) Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association. Circulation 103:2994\u20133018","journal-title":"Circulation"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jvir.2009.03.043","volume":"20","author":"IE Hoefer","year":"2009","unstructured":"Hoefer IE, Stroes ESG, Pasterkamp G, Levi MM, Reekers JA, Verhagen HJM, Meijers JC, Humphries JE, Rotmans JI (2009) Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis. J Vasc Interv Radiol 20:951\u2013958","journal-title":"J Vasc Interv Radiol"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1055\/s-2008-1047567","volume":"29","author":"DA Hoppensteadt","year":"2008","unstructured":"Hoppensteadt DA, Jeske W, Walenga J, Fareed J (2008) The future of anticoagulation. Semin Respir Crit Care Med 29:90\u201399","journal-title":"Semin Respir Crit Care Med"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1152\/ajplegacy.1918.47.3.328","volume":"47","author":"W Howell","year":"1918","unstructured":"Howell W, Holt E (1918) Two new factors in blood coagulation-heparin and pro-antithrombin. Am J Phys 47:328\u2013341","journal-title":"Am J Phys"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/S0021-9258(19)81051-7","volume":"257","author":"M Hoylaerts","year":"1982","unstructured":"Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 257:2912\u20132919","journal-title":"J Biol Chem"},{"key":"15_CR98","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nutres.2009.01.009","volume":"29","author":"CH Hsia","year":"2009","unstructured":"Hsia CH, Shen MC, Lin JS, Wen YK, Hwang KL, Cham TM, Yang NC (2009) Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects. Nutr Res 29:190\u2013196","journal-title":"Nutr Res"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1160\/TH08-04-0225","volume":"100","author":"JA Hunt","year":"2008","unstructured":"Hunt JA, Petteway SR, Scuderi P, Novokhatny V (2008) Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin. Thromb Haemost 100:413\u2013419","journal-title":"Thromb Haemost"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1472-765X.2006.01966.x","volume":"43","author":"Y Inatsu","year":"2006","unstructured":"Inatsu Y, Nakamura N, Yuriko Y, Fushimi T, Watanasiritum L, Kawamoto S (2006) Characterization of Bacillus subtilis strains in Thua nao, a traditional fermented soybean food in northern Thailand. Lett Appl Microbiol 43:237\u2013242","journal-title":"Lett Appl Microbiol"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1053\/euhj.2000.2498","volume":"21","author":"InTIME-II Investigators","year":"2000","unstructured":"InTIME-II Investigators (2000) Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 21:2005\u20132013","journal-title":"Eur Heart J"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","volume":"339","author":"ISIS-3","year":"1992","unstructured":"ISIS-3 (1992) A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 339:753\u2013770","journal-title":"Lancet"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1021\/bi00269a001","volume":"21","author":"KW Jackson","year":"1982","unstructured":"Jackson KW, Tang J (1982) Complete amino acid sequence of streptokinase and its homology with serine proteases. Biochemistry 21:6620\u20136625","journal-title":"Biochemistry"},{"key":"15_CR104","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/STROKEAHA.107.507376","volume":"39","author":"R Jahan","year":"2008","unstructured":"Jahan R, Stewart D, Vinters HV, Yong W, Vinuela F, Vandeberg P, Marder VJ (2008) Middle cerebral artery occlusion in the rabbit using selective angiography: application for assessment of thrombolysis. Stroke 39:1613\u20131615","journal-title":"Stroke"},{"key":"15_CR105","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/IBPC.S99553","volume":"9","author":"GS Jensen","year":"2016","unstructured":"Jensen GS, Lenninger M, Ero MP, Benson KF (2016) Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial. Integr Blood Press Control 9:95\u2013104","journal-title":"Integr Blood Press Control"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1016685411809","volume":"17","author":"YK Jeong","year":"2001","unstructured":"Jeong YK, Park JU, Baek H, Park SH, Kong IS, Kim DW, Joo WH (2001) Purification and biochemical characterization of a fibrinolytic enzyme from Bacillus subtilis BK-17. World J Microbiol Biotechnol 17:89\u201392","journal-title":"World J Microbiol Biotechnol"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"969","DOI":"10.4014\/jmb.1401.01034","volume":"24","author":"SJ Jeong","year":"2014","unstructured":"Jeong SJ, Cho KM, Lee CK, Kim GM, Shin JH, Kim JS, Kim JH (2014) Overexpression of aprE2, a fibrinolytic enzyme gene from Bacillus subtilis CH3-5, in Escherichia coli and the properties of AprE2. J Microbiol Biotechnol 24:969\u2013978","journal-title":"J Microbiol Biotechnol"},{"key":"15_CR108","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4014\/jmb.1409.09087","volume":"25","author":"SJ Jeong","year":"2015","unstructured":"Jeong SJ, Heo K, Park JY, Lee KW, Park JY, Joo SH, Kim JH (2015) Characterization of AprE176, a fibrinolytic enzyme from Bacillus subtilis HK176. J Microbiol Biotechnol 25:89\u201397","journal-title":"J Microbiol Biotechnol"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bcab.2015.05.006","volume":"4","author":"SB Jhample","year":"2015","unstructured":"Jhample SB, Bhagwat PK, Dandge PB (2015) Statistical media optimization for enhanced production of fibrinolytic enzyme from newly isolated Proteus penneri SP-20. Biocatal Agric Biotechnol 4:370\u2013379","journal-title":"Biocatal Agric Biotechnol"},{"key":"15_CR110","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1084\/jem.95.5.449","volume":"95","author":"AJ Johnson","year":"1952","unstructured":"Johnson AJ, Tillett WS (1952) The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J Exp Med 95:449\u2013464","journal-title":"J Exp Med"},{"key":"15_CR111","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s11274-012-1055-9","volume":"28","author":"X Ju","year":"2012","unstructured":"Ju X, Cao X, Sun Y, Wang Z, Cao C, Liu J, Jiang J (2012) Purification and characterization of a fibrinolytic enzyme from Streptomyces sp. XZNUM 00004. World J Microbiol Biotechnol 28:2479\u20132486","journal-title":"World J Microbiol Biotechnol"},{"key":"15_CR112","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0140-6736(61)90738-3","volume":"278","author":"DG Julian","year":"1961","unstructured":"Julian DG (1961) Treatment of cardiac arrest in acute myocardial isch\u00e6mia and infarction. Lancet 278:840\u2013844","journal-title":"Lancet"},{"key":"15_CR113","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/0002-9149(92)90923-M","volume":"69","author":"J Kalbfleisch","year":"1992","unstructured":"Kalbfleisch J, Thadani U, LittleJohn JK, Brown G, Magorien R, Kutcher M, Taylor G, Maddox WT, Campbell WB, Perry J, Spann JF, Vetrovec G, Kent R, Armstrong PW (1992) Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reclusion following successful thrombolysis in acute myocardial infarction. Am J Cardiol 69:1120\u20131127","journal-title":"Am J Cardiol"},{"key":"15_CR114","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1016\/S0021-9258(17)39036-1","volume":"260","author":"S Kasai","year":"1985","unstructured":"Kasai S, Arimura H, Nishida M, Suyama T (1985) Primary structure of single-chain pro-urokinase. J Biol Chem 260:12382\u201312389","journal-title":"J Biol Chem"},{"key":"15_CR115","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/01.WCB.0000137868.50767.E8","volume":"24","author":"J Kaur","year":"2004","unstructured":"Kaur J, Zhao Z, Klein GM, Lo EH, Buchan AM (2004) The neurotoxicity of tissue plasminogen activator. J Cereb Blood Flow Metab 24:945\u2013963","journal-title":"J Cereb Blood Flow Metab"},{"key":"15_CR116","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0735-1097(97)00074-0","volume":"29","author":"C Kawai","year":"1997","unstructured":"Kawai C, Yui Y, Hosoda S, Nobuyoshi M, Suzuki S, Sato H, Takatsu F, Motomiya T, Kanmatsuse K, Kodama K, Yabe Y, Minamino T, Kimata S, Nakashima M (1997) A prospective, randomized, double-blind multicenter trial of a single bolus injection of the novel modified t-PA E6010 in the treatment of acute myocardial infarction: comparison with native t-PA. E6010 Study Group. J Am Coll Cardiol 29:1447\u20131453","journal-title":"J Am Coll Cardiol"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1254\/jjp.63.9","volume":"63","author":"T Kawasaki","year":"1993","unstructured":"Kawasaki T, Katoh M, Kaku S, Gushima H, Takenaka T, Yui Y, Kawai C (1993) Thrombolytic activity of a novel modified tissue-type plasminogen activator, YM866, in a canine model of coronary artery thrombosis. Jpn J Pharmacol 63:9\u201316","journal-title":"Jpn J Pharmacol"},{"key":"15_CR118","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1271\/bbb.65.356","volume":"65","author":"JH Kim","year":"2001","unstructured":"Kim JH, Kim YS (2001) Characterization of a metalloenzyme from a wild mushroom, Tricholoma saponaceum. Biosci Biotechnol Biochem 65:356\u2013362","journal-title":"Biosci Biotechnol Biochem"},{"key":"15_CR119","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.mycres.2008.01.029","volume":"112","author":"JS Kim","year":"2008","unstructured":"Kim JS, Kim JE, Choi BS, Park SE, Sapkota K, Kim S, Lee HH, Kim CS, Park Y, Kim MK, Kim YS, Kim SJ (2008) Purification and characterization of fibrinolytic metalloprotease from Perenniporia fraxinea mycelia. Mycol Res 112:990\u2013998","journal-title":"Mycol Res"},{"key":"15_CR120","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.procbio.2011.04.005","volume":"46","author":"HC Kim","year":"2011","unstructured":"Kim HC, Choi BS, Sapkota K, Kim S, Lee HJ, Yoo JC, Kim SJ (2011) Purification and characterization of a novel, highly potent fibrinolytic enzyme from Paecilomyces tenuipes. Process Biochem 46:1545\u20131553","journal-title":"Process Biochem"},{"key":"15_CR121","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0021-9258(18)66098-3","volume":"204","author":"DL Kline","year":"1953","unstructured":"Kline DL (1953) The purification and crystallization of plasminogen (profibrinolysin). J Biol Chem 204:949\u2013955","journal-title":"J Biol Chem"},{"key":"15_CR122","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cca.2003.11.008","volume":"137","author":"JH Ko","year":"2004","unstructured":"Ko JH, Yan JP, Zhu L, Qi YP (2004) Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02. Comp Biochem Physiol C Toxicol Pharmacol 137:65\u201374","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"15_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/protein\/5.1.93","volume":"5","author":"U Kohnert","year":"1992","unstructured":"Kohnert U, Rudolph R, Verheijen JH, Weening-Verhoeff EJ, Stern A, Opitz U, Martin U, Lill H, Prinz H, Lechner M (1992) Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng 5:93\u2013100","journal-title":"Protein Eng"},{"key":"15_CR124","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1055\/s-0038-1650234","volume":"75","author":"K Kolev","year":"1996","unstructured":"Kolev K, Komorowicz E, Owen WG, Machovich R (1996) Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G. Thromb Haemost 75:140\u2013146","journal-title":"Thromb Haemost"},{"key":"15_CR125","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/01.RES.82.10.1102","volume":"82","author":"E Komorowicz","year":"1998","unstructured":"Komorowicz E, Kolev K, Lerant I, Machovich R (1998) Flow rate-modulated dissolution of fibrin with clot-embedded and circulating proteases. Circ Res 82:1102\u20131108","journal-title":"Circ Res"},{"key":"15_CR126","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJM198511283132204","volume":"313","author":"G Koren","year":"1985","unstructured":"Koren G, Weiss AT, Hasin Y, Appelbaum D, Welber S, Rozenman Y, Lotan C, Mosseri M, Sapoznikov D, Luria MH (1985) Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med 313:1384\u20131389","journal-title":"N Engl J Med"},{"key":"15_CR127","doi-asserted-by":"publisher","first-page":"6647","DOI":"10.1007\/s00253-013-5052-1","volume":"97","author":"E Kotb","year":"2013","unstructured":"Kotb E (2013) Activity assessment of microbial fibrinolytic enzymes. Appl Microbiol Biotechnol 97:6647\u20136665","journal-title":"Appl Microbiol Biotechnol"},{"key":"15_CR128","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/btpr.1918","volume":"30","author":"E Kotb","year":"2014","unstructured":"Kotb E (2014) The biotechnological potential of fibrinolytic enzymes in the dissolution of endogenous blood thrombi. Biotechnol Prog 30:656\u2013672","journal-title":"Biotechnol Prog"},{"key":"15_CR129","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1134\/S0006350917020105","volume":"62","author":"TA Kovalenko","year":"2017","unstructured":"Kovalenko TA, Panteleev MA, Sveshnikova AN (2017) The mechanisms and kinetics of initiation of blood coagulation by the extrinsic tenase complex. Biophysics 62:291\u2013300","journal-title":"Biophysics"},{"key":"15_CR130","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0378-1119(91)90155-5","volume":"105","author":"J Kratzschmar","year":"1991","unstructured":"Kratzschmar J, Haendler B, Langer G, Boidol W, Bringmann P, Alagon A, Donner P, Schleuning WD (1991) The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene 105:229\u2013237","journal-title":"Gene"},{"key":"15_CR131","volume-title":"Diseases of the heart muscle and nervous heart disease","author":"L Krehl","year":"1901","unstructured":"Krehl L (1901) Diseases of the heart muscle and nervous heart disease. Alfred Holder, Vienna"},{"key":"15_CR132","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-981-10-4284-3_2","volume-title":"Bioresources and bioprocess in biotechnology: volume 2: exploring potential biomolecules","author":"SS Kumar","year":"2017","unstructured":"Kumar SS, Sabu A (2017) Therapeutic enzymes. In: Sugathan S, Pradee NS, Sabu A (eds) Bioresources and bioprocess in biotechnology: volume 2: exploring potential biomolecules. Springer Singapore, Singapore, pp 45\u201373"},{"key":"15_CR133","doi-asserted-by":"publisher","first-page":"11601","DOI":"10.1038\/srep11601","volume":"5","author":"Y Kurosawa","year":"2015","unstructured":"Kurosawa Y, Nirengi S, Homma T, Esaki K, Ohta M, Clark JF, Hamaoka T (2015) A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci Rep 5:11601","journal-title":"Sci Rep"},{"key":"15_CR134","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijbiomac.2013.07.009","volume":"61","author":"BP Lakshmi","year":"2013","unstructured":"Lakshmi BP, Prakasham RS (2013) A fibrinolytic, alkaline and thermostable metalloprotease from the newly isolated Serratia sp RSPB11. Int J Biol Macromol 61:479\u2013486","journal-title":"Int J Biol Macromol"},{"key":"15_CR135","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","volume":"106","author":"DA Lane","year":"2005","unstructured":"Lane DA, Philippou H, Huntington JA (2005) Directing thrombin. Blood 106:2605\u20132612","journal-title":"Blood"},{"key":"15_CR136","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1126\/science.102.2641.151","volume":"102","author":"K Lange","year":"1945","unstructured":"Lange K, Boyd LJ, Loewe L (1945) The functional pathology of frostbite and the prevention of gangrene in experimental animals and humans. Science 102:151\u2013152","journal-title":"Science"},{"key":"15_CR137","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1182\/blood.V96.4.1425","volume":"96","author":"Y Laroche","year":"2000","unstructured":"Laroche Y, Heymans S, Capaert S, De Cock F, Demarsin E, Collen D (2000) Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes. Blood 96:1425\u20131432","journal-title":"Blood"},{"key":"15_CR138","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1182\/blood.V73.7.1842.1842","volume":"73","author":"GR Larsen","year":"1989","unstructured":"Larsen GR, Metzger M, Henson K, Blue Y, Horgan P (1989) Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat. Blood 73:1842\u20131850","journal-title":"Blood"},{"key":"15_CR139","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.1016\/S0021-9258(18)92955-8","volume":"266","author":"GR Larsen","year":"1991","unstructured":"Larsen GR, Timony GA, Horgan PG, Barone KM, Henson KS, Angus LB, Stoudemire JB (1991) Protein engineering of novel plasminogen activators with increased thrombolytic potency in rabbits relative to activase. J Biol Chem 266:8156\u20138161","journal-title":"J Biol Chem"},{"key":"15_CR140","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","volume":"72","author":"CJ Lee","year":"2011","unstructured":"Lee CJ, Ansell JE (2011) Direct thrombin inhibitors. Br J Clin Pharmacol 72:581\u2013592","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR141","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pep.2005.05.004","volume":"43","author":"SY Lee","year":"2005","unstructured":"Lee SY, Kim JS, Kim JE, Sapkota K, Shen MH, Kim S, Chun HS, Yoo JC, Choi HS, Kim MK, Kim SJ (2005) Purification and characterization of fibrinolytic enzyme from cultured mycelia of Armillaria mellea. Protein Expr Purif 43:10\u201317","journal-title":"Protein Expr Purif"},{"key":"15_CR142","first-page":"264","volume":"16","author":"JS Lee","year":"2006","unstructured":"Lee JS, Hyung-Suk B, Sang-Shin P (2006) Purification and characterization of two novel fibrinolytic proteases from mushroom, Fomitella fraxinea. J Microbiol Biotechnol 16:264\u2013271","journal-title":"J Microbiol Biotechnol"},{"key":"15_CR143","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/BF02980222","volume":"30","author":"CK Lee","year":"2007","unstructured":"Lee CK, Shin JS, Kim BS, Cho IH, Kim YS, Lee EB (2007) Antithrombotic effects by oral administration of novel proteinase fraction from earthworm Eisenia andrei on venous thrombosis model in rats. Arch Pharm Res 30:475\u2013480","journal-title":"Arch Pharm Res"},{"key":"15_CR144","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2174\/1568016043356183","volume":"2","author":"G Leone","year":"2004","unstructured":"Leone G, Rossi E, Leone AM, De Stefano V (2004) Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies. Curr Med Chem Cardiovasc Hematol Agents 2:311\u2013326","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"15_CR145","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1161\/01.CIR.103.14.1838","volume":"103","author":"BE Lewis","year":"2001","unstructured":"Lewis BE, Wallis DE, Berkowitz SD, Matthai WH, Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi PK, Jang IK, Rifkin SD, Moran J, Hursting MJ, Kelton JG (2001) Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103:1838\u20131843","journal-title":"Circulation"},{"key":"15_CR146","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/archinte.163.15.1849","volume":"163","author":"BE Lewis","year":"2003","unstructured":"Lewis BE, Wallis DE, Leya F, Hursting MJ, Kelton JG, Argatroban-915 Investigators (2003) Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 163:1849\u20131856","journal-title":"Arch Intern Med"},{"key":"15_CR147","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ptr.2246","volume":"21","author":"H Li","year":"2007","unstructured":"Li H, Hu Z, Yuan J, Fan H, Chen W, Wang S, Zheng S, Zheng Z, Zou G (2007) A novel extracellular protease with fibrinolytic activity from the culture supernatant of Cordyceps sinensis: purification and characterization. Phytother Res 21:1234\u20131241","journal-title":"Phytother Res"},{"key":"15_CR06","doi-asserted-by":"publisher","first-page":"e6667","DOI":"10.1097\/MD.0000000000006667","volume":"96","author":"X Li","year":"2017","unstructured":"Li X, Ling L, Li C, Ma Q (2017) Efficacy and safety of desmoteplase in acute ischemic stroke patients: a systematic review and meta-analysis. Medicine 96:e6667","journal-title":"Medicine"},{"key":"15_CR148","doi-asserted-by":"publisher","first-page":"11826","DOI":"10.1016\/S0021-9258(18)99031-9","volume":"266","author":"HR Lijnen","year":"1991","unstructured":"Lijnen HR, Van Hoef B, De Cock F, Okada K, Ueshima S, Matsuo O, Collen D (1991) On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J Biol Chem 266:11826\u201311832","journal-title":"J Biol Chem"},{"key":"15_CR149","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0167-4838(98)00144-7","volume":"1387","author":"D Louis","year":"1998","unstructured":"Louis D, Bernillon J, Wallach JM (1998) Specificity of Pseudomonas aeruginosa serralysin revisited, using biologically active peptides as substrates. Biochim Biophys Acta Protein Struct Mol Enzymol 1387:378\u2013386","journal-title":"Biochim Biophys Acta Protein Struct Mol Enzymol"},{"key":"15_CR150","first-page":"69","volume":"18","author":"CL Lu","year":"2010","unstructured":"Lu CL, Chen S, Chen SN (2010a) Purification and characterization of a novel fibrinolytic protease from Schizophyllum commune. J Food Drug Anal 18:69\u201376","journal-title":"J Food Drug Anal"},{"key":"15_CR151","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.thromres.2010.08.003","volume":"126","author":"F Lu","year":"2010","unstructured":"Lu F, Lu Z, Bie X, Yao Z, Wang Y, Lu Y, Guo Y (2010b) Purification and characterization of a novel anticoagulant and fibrinolytic enzyme produced by endophytic bacterium Paenibacillus polymyxa EJS-3. Thromb Res 126:349\u2013355","journal-title":"Thromb Res"},{"key":"15_CR152","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1182\/blood-2004-02-0621","volume":"104","author":"N Lubenow","year":"2004","unstructured":"Lubenow N, Eichler P, Lietz T, Farner B, Greinacher A (2004) Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies. Blood 104:3072\u20133077","journal-title":"Blood"},{"key":"15_CR153","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1016\/S0021-9258(18)32614-0","volume":"258","author":"MA Lucas","year":"1983","unstructured":"Lucas MA, Fretto LJ, McKee PA (1983) The binding of human plasminogen to fibrin and fibrinogen. J Biol Chem 258:4249\u20134256","journal-title":"J Biol Chem"},{"key":"15_CR154","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10529-006-9290-5","volume":"29","author":"Z Ma","year":"2007","unstructured":"Ma Z, Lu W, Wu S, Chen J, Sun Z, Liu JN (2007) Expression and characterization of recombinant human micro-plasminogen. Biotechnol Lett 29:517\u2013523","journal-title":"Biotechnol Lett"},{"key":"15_CR155","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/202498a0","volume":"202","author":"RG Macfarlane","year":"1964","unstructured":"Macfarlane RG (1964) An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498\u2013499","journal-title":"Nature"},{"key":"15_CR156","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/159779a0","volume":"159","author":"RG Macfarlane","year":"1947","unstructured":"Macfarlane RG, Pilling J (1947) Fibrinolytic activity of normal urine. Nature 159:779","journal-title":"Nature"},{"key":"15_CR157","doi-asserted-by":"publisher","first-page":"7558","DOI":"10.1074\/jbc.270.13.7558","volume":"270","author":"EL Madison","year":"1995","unstructured":"Madison EL, Coombs GS, Corey DR (1995) Substrate specificity of tissue type plasminogen activator characterization of the fibrin independent specificity of t-PA for plasminogen. J Biol Chem 270:7558\u20137562","journal-title":"J Biol Chem"},{"key":"15_CR158","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jbiosc.2011.10.023","volume":"113","author":"PM Mahajan","year":"2012","unstructured":"Mahajan PM, Nayak S, Lele SS (2012) Fibrinolytic enzyme from newly isolated marine bacterium Bacillus subtilis ICTF-1: media optimization, purification and characterization. J Biosci Bioeng 113:307\u2013314","journal-title":"J Biosci Bioeng"},{"key":"15_CR159","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/oxfordjournals.eurheartj.a014716","volume":"17","author":"A Malcolm","year":"1996","unstructured":"Malcolm A, Keltai M, Walsh M (1996) ESPRIT: a european study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction. Eur Heart J 17:1522\u20131531","journal-title":"Eur Heart J"},{"key":"15_CR160","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1073\/pnas.81.11.3557","volume":"81","author":"H Malke","year":"1984","unstructured":"Malke H, Ferretti JJ (1984) Streptokinase: cloning, expression, and excretion by Escherichia coli. Proc Natl Acad Sci U S A 81:3557\u20133561","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR161","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.procbio.2011.03.016","volume":"46","author":"P Mander","year":"2011","unstructured":"Mander P, Cho SS, Simkhada JR, Choi YH, Yoo JC (2011) A low molecular weight chymotrypsin-like novel fibrinolytic enzyme from Streptomyces sp. CS624. Process Biochem 46:1449\u20131455","journal-title":"Process Biochem"},{"key":"15_CR162","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jhmas\/55.1.37","volume":"55","author":"JA Marcum","year":"2000","unstructured":"Marcum JA (2000) The origin of the dispute over the discovery of heparin. J Hist Med Allied Sci 55:37\u201366","journal-title":"J Hist Med Allied Sci"},{"key":"15_CR163","doi-asserted-by":"publisher","first-page":"802","DOI":"10.7326\/0003-4819-90-5-802","volume":"90","author":"VJ Marder","year":"1979","unstructured":"Marder VJ (1979) The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med 90:802\u2013808","journal-title":"Ann Intern Med"},{"key":"15_CR164","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1538-7836.2011.04370.x","volume":"1","author":"VJ Marder","year":"2011","unstructured":"Marder VJ (2011) Historical perspective and future direction of thrombolysis research: the re-discovery of plasmin. J Thromb Haemost 1:364\u2013373","journal-title":"J Thromb Haemost"},{"key":"15_CR165","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1538-7836.2009.03701.x","volume":"8","author":"VJ Marder","year":"2010","unstructured":"Marder VJ, Novokhatny V (2010) Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential. J Thromb Haemost 8:433\u2013444","journal-title":"J Thromb Haemost"},{"key":"15_CR166","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1056\/NEJM198806093182306","volume":"318","author":"VJ Marder","year":"1988","unstructured":"Marder VJ, Sherry S (1988) Thrombolytic therapy: current status (1). N Engl J Med 318:1512\u20131520","journal-title":"N Engl J Med"},{"key":"15_CR167","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1055\/s-0037-1616127","volume":"86","author":"VJ Marder","year":"2001","unstructured":"Marder VJ, Landskroner K, Novokhatny V, Zimmerman TP, Kong M, Kanouse JJ, Jesmok G (2001) Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit. Thromb Haemost 86:739\u2013745","journal-title":"Thromb Haemost"},{"key":"15_CR168","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0041-0101(98)00126-3","volume":"36","author":"FS Markland","year":"1998","unstructured":"Markland FS (1998) Snake venoms and the hemostatic system. Toxicon 36:1749\u20131800","journal-title":"Toxicon"},{"key":"15_CR169","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/clpt.1991.160","volume":"50","author":"U Martin","year":"1991","unstructured":"Martin U, von Mollendorff E, Akpan W, Kientsch-Engel R, Kaufmann B, Neugebauer G (1991a) Dose-ranging study of the novel recombinant plasminogen activator BM 06.022 in healthy volunteers. Clin Pharmacol Ther 50:429\u2013436","journal-title":"Clin Pharmacol Ther"},{"key":"15_CR170","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1055\/s-0038-1646461","volume":"66","author":"U Martin","year":"1991","unstructured":"Martin U, von Mollendorff E, Akpan W, Kientsch-Engel R, Kaufmann B, Neugebauer G (1991b) Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator BM 06.022 in healthy volunteers. Thromb Haemost 66:569\u2013574","journal-title":"Thromb Haemost"},{"key":"15_CR171","first-page":"203","volume":"10","author":"EC Mason","year":"1924","unstructured":"Mason EC (1924) A note on the use of heparin in blood transfusion. J Lab Clin Med 10:203\u2013206","journal-title":"J Lab Clin Med"},{"key":"15_CR172","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbapap.2011.05.008","volume":"1814","author":"MK Massaoud","year":"2011","unstructured":"Massaoud MK, Marokh\u00e1zi J, Venekei I (2011) Enzymatic characterization of a serralysin-like metalloprotease from the entomopathogen bacterium, Xenorhabdus. Biochim Biophys Acta, Proteins Proteomics 1814:1333\u20131339","journal-title":"Biochim Biophys Acta, Proteins Proteomics"},{"key":"15_CR173","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0305-0491(97)00303-9","volume":"119","author":"K Matsubara","year":"1998","unstructured":"Matsubara K, Sumi H, Hori K, Miyazawa K (1998) Purification and characterization of two fibrinolytic enzymes from a marine green alga, Codium intricatum. Comp Biochem Physiol B Biochem Mol Biol 119:177\u2013181","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"15_CR174","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/S0031-9422(99)00356-8","volume":"52","author":"K Matsubara","year":"1999","unstructured":"Matsubara K, Hori K, Matsuura Y, Miyazawa K (1999) A fibrinolytic enzyme from a marine green alga, Codium latum. Phytochemistry 52:993\u2013999","journal-title":"Phytochemistry"},{"key":"15_CR175","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0305-0491(99)00161-3","volume":"125","author":"K Matsubara","year":"2000","unstructured":"Matsubara K, Hori K, Matsuura Y, Miyazawa K (2000) Purification and characterization of a fibrinolytic enzyme and identification of fibrinogen clotting enzyme in a marine green alga, Codium divaricatum. Comp Biochem Physiol B Biochem Mol Biol 125:137\u2013143","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"15_CR176","first-page":"324","volume":"20","author":"J McLean","year":"1946","unstructured":"McLean J, Johnson AB (1946) Gangrene following fracture treated with heparin; papaverine, and intermittent venous occlusion; report of a case; reasons for using heparin. Surgery 20:324\u2013336","journal-title":"Surgery"},{"key":"15_CR177","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/01.ATV.12.2.212","volume":"12","author":"MJ Mellott","year":"1992","unstructured":"Mellott MJ, Stabilito II, Holahan MA, Cuca GC, Wang S, Li P, Barrett JS, Lynch JJ, Gardell SJ (1992) Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis. Arterioscler Thromb 12:212\u2013221","journal-title":"Arterioscler Thromb"},{"key":"15_CR178","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2170\/jjphysiol.41.461","volume":"41","author":"H Mihara","year":"1991","unstructured":"Mihara H, Sumi H, Yoneta T, Mizumoto H, Ikeda R, Seiki M, Maruyama M (1991) A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. Jpn J Physiol 41:461\u2013472","journal-title":"Jpn J Physiol"},{"key":"15_CR179","first-page":"310","volume":"34","author":"K Miyata","year":"1970","unstructured":"Miyata K, Maejima K, Tomoda K, Isono M (1970) Serratia protease. Part I. Purification and general properties of the enzyme. Agric Biol Chem 34:310\u2013318","journal-title":"Agric Biol Chem"},{"key":"15_CR180","first-page":"460","volume":"35","author":"K Miyata","year":"1971","unstructured":"Miyata K, Tomoda K, Isono M (1971) Serratia protease. Part III. Characteristics of the enzyme as metalloenzyme. Agric Biol Chem 35:460\u2013467","journal-title":"Agric Biol Chem"},{"key":"15_CR181","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jbiosc.2013.10.019","volume":"117","author":"SM Moon","year":"2014","unstructured":"Moon SM, Kim JS, Kim HJ, Choi MS, Park BR, Kim SG, Ahn H, Chun HS, Shin YK, Kim JJ, Kim DK, Lee SY, Seo YW, Kim YH, Kim CS (2014) Purification and characterization of a novel fibrinolytic \u03b1 chymotrypsin like serine metalloprotease from the edible mushroom, Lyophyllum shimeji. J Biosci Bioeng 117:544\u2013550","journal-title":"J Biosci Bioeng"},{"key":"15_CR182","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1470-8744.1994.tb00308.x","volume":"20","author":"N Moriya","year":"1994","unstructured":"Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, Kakinuma A (1994) Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem 20:101\u2013108","journal-title":"Biotechnol Appl Biochem"},{"key":"15_CR183","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1182\/blood.V58.1.97.97","volume":"58","author":"LA Moroz","year":"1981","unstructured":"Moroz LA (1981) Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase. Blood 58:97\u2013104","journal-title":"Blood"},{"key":"15_CR184","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1472-6750-12-96","volume":"12","author":"M Moussa","year":"2012","unstructured":"Moussa M, Ibrahim M, El Ghazaly M, Rohde J, Gnoth S, Anton A, Kensy F, Mueller F (2012) Expression of recombinant staphylokinase in the methylotrophic yeast Hansenula polymorpha. BMC Biotechnol 12:96","journal-title":"BMC Biotechnol"},{"key":"15_CR185","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.biochi.2012.02.027","volume":"94","author":"AK Mukherjee","year":"2012","unstructured":"Mukherjee AK, Rai SK, Thakur R, Chattopadhyay P, Kar SK (2012) Bafibrinase: a non-toxic, non-hemorrhagic, direct-acting fibrinolytic serine protease from Bacillus sp. strain AS-S20-I exhibits in vivo anticoagulant activity and thrombolytic potency. Biochimie 94:1300\u20131308","journal-title":"Biochimie"},{"key":"15_CR186","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1128\/jb.171.4.2202-2208.1989","volume":"171","author":"J Muller","year":"1989","unstructured":"Muller J, Reinert H, Malke H (1989) Streptokinase mutations relieving Escherichia coli K-12 (prlA4) of detriments caused by the wild-type skc gene. J Bacteriol 171:2202\u20132208","journal-title":"J Bacteriol"},{"key":"15_CR187","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/bms.1200230606","volume":"23","author":"D Muller","year":"1994","unstructured":"Muller D, Domon B, Karas M, van Oostrum J, Richter WJ (1994) Characterization and direct glycoform profiling of a hybrid plasminogen activator by matrix-assisted laser desorption and electrospray mass spectrometry: correlation with high-performance liquid chromatographic and nuclear magnetic resonance analyses of the released glycans. Biol Mass Spectrom 23:330\u2013338","journal-title":"Biol Mass Spectrom"},{"key":"15_CR188","first-page":"530","volume":"9","author":"MA Munger","year":"1990","unstructured":"Munger MA, Forrence EA (1990) Anistreplase: a new thrombolytic for the treatment of acute myocardial infarction. Clin Pharm 9:530\u2013540","journal-title":"Clin Pharm"},{"key":"15_CR189","first-page":"163","volume":"2","author":"DWG Murray","year":"1937","unstructured":"Murray DWG, Jaques LB, Perrett TS, Best CH (1937) Heparin and the thrombosis of veins following injury. Surgery 2:163\u2013187","journal-title":"Surgery"},{"key":"15_CR190","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1538-7836.2003.00078.x","volume":"1","author":"N Nagai","year":"2003","unstructured":"Nagai N, Demarsin E, Van Hoef B, Wouters S, Cingolani D, Laroche Y, Collen D (2003) Recombinant human microplasmin: production and potential therapeutic properties. J Thromb Haemost 1:307\u2013313","journal-title":"J Thromb Haemost"},{"key":"15_CR191","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1093\/nar\/14.14.5843","volume":"14","author":"K Nakahama","year":"1986","unstructured":"Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee IS, Hase T, Matsubara H (1986) Cloning and sequencing of serratia protease gene. Nucleic Acids Res 14:5843\u20135855","journal-title":"Nucleic Acids Res"},{"key":"15_CR192","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1271\/bbb.56.1869","volume":"56","author":"T Nakamura","year":"1992","unstructured":"Nakamura T, Yamagata Y, Ichishima E (1992) Nucleotide sequence of the subtilisin NAT gene, aprN, of Bacillus subtilis (natto). Biosci Biotechnol Biochem 56:1869\u20131871","journal-title":"Biosci Biotechnol Biochem"},{"key":"15_CR193","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/MBC.0b013e3282f54568","volume":"19","author":"B Niego","year":"2008","unstructured":"Niego B, Horvath A, Coughlin PB, Pugsley MK, Medcalf RL (2008) Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid. Blood Coagul Fibrinolysis 19:322\u2013324","journal-title":"Blood Coagul Fibrinolysis"},{"key":"15_CR194","first-page":"121","volume":"82","author":"TK Nordt","year":"1999","unstructured":"Nordt TK, Moser M, Kohler B, Kubler W, Bode C (1999) Pharmacokinetics and pharmacodynamics of lanoteplase (n-PA). Thromb Haemost 82:121\u2013123","journal-title":"Thromb Haemost"},{"key":"15_CR195","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/biof.5520220138","volume":"22","author":"K Omura","year":"2004","unstructured":"Omura K, Hitosugi M, Kaketani K, Zhu X, Maeda H, Tokudome S (2004) Fibrinolytic and anti-thrombotic effect of NKCP, the protein layer from Bacillus subtilis (natto). Biofactors 22:185\u2013187","journal-title":"Biofactors"},{"key":"15_CR196","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/bja\/aet402","volume":"111","author":"AD Oprea","year":"2013","unstructured":"Oprea AD, Popescu WM (2013) Perioperative management of antiplatelet therapy. Br J Anaesth 111:i3\u2013i17","journal-title":"Br J Anaesth"},{"key":"15_CR02","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10016-001-0318-y","volume":"16","author":"K Ouriel","year":"2002","unstructured":"Ouriel K (2002) Current status of thrombolysis for peripheral arterial occlusive disease. Ann Vasc Surg 16:797\u2013804","journal-title":"Ann Vasc Surg"},{"key":"15_CR197","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/294258","volume":"2010","author":"R Pan","year":"2010","unstructured":"Pan R, Zhang ZJ, He RQ (2010) Earthworm protease. Appl Environ Soil Sci 2010:294258","journal-title":"Appl Environ Soil Sci"},{"key":"15_CR198","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1271\/bbb.70193","volume":"71","author":"SE Park","year":"2007","unstructured":"Park SE, Li MH, Kim JS, Sapkota K, Kim JE, Choi BS, Yoon YH, Lee JC, Lee HH, Kim CS, Kim SJ (2007) Purification and characterization of a fibrinolytic protease from a culture supernatant of Flammulina velutipes mycelia. Biosci Biotechnol Biochem 71:2214\u20132222","journal-title":"Biosci Biotechnol Biochem"},{"key":"15_CR199","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3746\/pnf.2012.17.1.078","volume":"17","author":"KJ Park","year":"2012","unstructured":"Park KJ, Kang JI, Kim TS, Yeo IH (2012) The antithrombotic and fibrinolytic effect of natto in hypercholesterolemia rats. Prev Nutr Food Sci 17:78\u201382","journal-title":"Prev Nutr Food Sci"},{"key":"15_CR200","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0140-6736(00)96049-5","volume":"211","author":"J Parkinson","year":"1928","unstructured":"Parkinson J, Bedford DE (1928) Cardiac infarction and coronary thrombosis. Lancet 211:4\u201311","journal-title":"Lancet"},{"key":"15_CR201","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.plaphy.2011.12.004","volume":"52","author":"GK Patel","year":"2012","unstructured":"Patel GK, Kawale AA, Sharma AK (2012) Purification and physicochemical characterization of a serine protease with fibrinolytic activity from latex of a medicinal herb Euphorbia hirta. Plant Physiol Biochem 52:104\u2013111","journal-title":"Plant Physiol Biochem"},{"key":"15_CR202","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0014-5793(84)80473-1","volume":"171","author":"L Patthy","year":"1984","unstructured":"Patthy L, Trexler M, Vali Z, Banyai L, Varadi A (1984) Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases. FEBS Lett 171:131\u2013136","journal-title":"FEBS Lett"},{"key":"15_CR203","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0950-3536(05)80092-7","volume":"7","author":"JD Pearson","year":"1994","unstructured":"Pearson JD (1994) Endothelial cell function and thrombosis. Baillieres Clin Haematol 7:441\u2013452","journal-title":"Baillieres Clin Haematol"},{"key":"15_CR204","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1096-4959(02)00183-5","volume":"134","author":"Y Peng","year":"2003","unstructured":"Peng Y, Huang Q, Zhang R, Zhang Y (2003) Purification and characterization of a fibrinolytic enzyme produced by Bacillus amyloliquefaciens DC-4 screened from douchi, a traditional Chinese soybean food. Comp Biochem Physiol B Biochem Mol Biol 134:45\u201352","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"15_CR205","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00253-005-0159-7","volume":"69","author":"Y Peng","year":"2005","unstructured":"Peng Y, Yang X, Zhang Y (2005) Microbial fibrinolytic enzymes: an overview of source, production, properties, and thrombolytic activity in vivo. Appl Microbiol Biotechnol 69:126\u2013132","journal-title":"Appl Microbiol Biotechnol"},{"key":"15_CR206","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/301214a0","volume":"301","author":"D Pennica","year":"1983","unstructured":"Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301:214\u2013221","journal-title":"Nature"},{"key":"15_CR207","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1538-7836.2003.00516.x","volume":"2","author":"PERSIST investigators","year":"2004","unstructured":"PERSIST investigators (2004) A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in deep vein thrombosis. A phase II evaluation. J Thromb Haemost 2:47\u201353","journal-title":"J Thromb Haemost"},{"key":"15_CR208","doi-asserted-by":"publisher","first-page":"11189","DOI":"10.1016\/S0021-9258(18)37940-7","volume":"263","author":"LC Petersen","year":"1988","unstructured":"Petersen LC, Lund LR, Nielsen LS, Dano K, Skriver L (1988) One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263:11189\u201311195","journal-title":"J Biol Chem"},{"key":"15_CR209","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2125.2006.02806.x","volume":"62","author":"M Pirmohamed","year":"2006","unstructured":"Pirmohamed M (2006) Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol 62:509\u2013511","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR210","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0006-3002(57)90194-4","volume":"24","author":"J Ploug","year":"1957","unstructured":"Ploug J, Kjeldgaard NO (1957) Urokinase an activator of plasminogen from human urine I. Isolation and properties. Biochim Biophys Acta 24:278\u2013282","journal-title":"Biochim Biophys Acta"},{"key":"15_CR211","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1472-6882-7-36","volume":"7","author":"S Prasad","year":"2007","unstructured":"Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF (2007) Effect of Fagonia arabica (Dhamasa) on in vitro thrombolysis. BMC Complement Altern Med 7:36","journal-title":"BMC Complement Altern Med"},{"key":"15_CR212","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1472-6882-13-25","volume":"13","author":"MA Rahman","year":"2013","unstructured":"Rahman MA, Sultana R, Bin Emran T, Islam MS, Rahman MA, Chakma JS, Rashid H, Hasan CMM (2013) Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity. BMC Complement Altern Med 13:25","journal-title":"BMC Complement Altern Med"},{"key":"15_CR213","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1055\/s-2007-981575","volume":"73","author":"R Rajesh","year":"2007","unstructured":"Rajesh R, Shivaprasad HV, Gowda CD, Nataraju A, Dhananjaya BL, Vishwanath BS (2007) Comparative study on plant latex proteases and their involvement in hemostasis: a special emphasis on clot inducing and dissolving properties. Planta Med 73:1061\u20131067","journal-title":"Planta Med"},{"key":"15_CR214","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0014-5793(82)80936-8","volume":"146","author":"M Ranby","year":"1982","unstructured":"Ranby M, Bergsdorf N, Pohl G, Wallen P (1982) Isolation of two variants of native one-chain tissue plasminogen activator. FEBS Lett 146:289\u2013292","journal-title":"FEBS Lett"},{"key":"15_CR215","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/pro.5560010505","volume":"1","author":"A Randolph","year":"1992","unstructured":"Randolph A, Chamberlain SH, Chu HL, Retzios AD, Markland FS, Masiarz FR (1992) Amino acid sequence of fibrolase, a direct-acting fibrinolytic enzyme from Agkistrodon contortrix contortrix venom. Protein Sci 1:590\u2013600","journal-title":"Protein Sci"},{"key":"15_CR216","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/01.STR.0000166050.84056.48","volume":"36","author":"C Reddrop","year":"2005","unstructured":"Reddrop C, Moldrich RX, Beart PM, Farso M, Liberatore GT, Howells DW, Petersen KU, Schleuning WD, Medcalf RL (2005) Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury. Stroke 36:1241\u20131246","journal-title":"Stroke"},{"key":"15_CR217","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/S0021-9258(17)35752-6","volume":"261","author":"DC Rijken","year":"1986","unstructured":"Rijken DC, Groeneveld E (1986) Isolation and functional characterization of the heavy and light chains of human tissue-type plasminogen activator. J Biol Chem 261:3098\u20133102","journal-title":"J Biol Chem"},{"key":"15_CR218","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/0005-2795(79)90205-8","volume":"580","author":"DC Rijken","year":"1979","unstructured":"Rijken DC, Wijngaards G, Zaal-de Jong M, Welbergen J (1979) Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 580:140\u2013153","journal-title":"Biochim Biophys Acta"},{"key":"15_CR219","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/0049-3848(80)90204-2","volume":"18","author":"DC Rijken","year":"1980","unstructured":"Rijken DC, Wijngaards G, Welbergen J (1980) Relationship between tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res 18:815\u2013830","journal-title":"Thromb Res"},{"key":"15_CR220","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1160\/TH03-07-0435","volume":"91","author":"DC Rijken","year":"2004","unstructured":"Rijken DC, Barrett-Bergshoeff MM, Jie AFH, Criscuoli M, Sakharov DV (2004) Clot penetration and fibrin binding of amediplase, a chimeric plasminogen activator (K2 tu-PA). Thromb Haemost 91:52\u201360","journal-title":"Thromb Haemost"},{"key":"15_CR221","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/S0021-9258(18)95967-3","volume":"242","author":"KC Robbins","year":"1967","unstructured":"Robbins KC, Summaria L, Hsieh B, Shah RJ (1967) The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J Biol Chem 242:2333\u20132342","journal-title":"J Biol Chem"},{"key":"15_CR09","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0145-305X(79)80055-5","volume":"3","author":"P Roch","year":"1979","unstructured":"Roch P (1979) Protein analysis of earthworm coelomic fluid: 1. polymorphic system of the natural hemolysin of Eisenia fetida andrei. Dev Comp Immunol 3:599\u2013608","journal-title":"Dev Comp Immunol"},{"key":"15_CR222","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1128\/iai.62.5.1749-1754.1994","volume":"62","author":"G Rosen","year":"1994","unstructured":"Rosen G, Naor R, Kutner S, Sela MN (1994) Characterization of fibrinolytic activities of Treponema denticola. Infect Immun 62:1749\u20131754","journal-title":"Infect Immun"},{"key":"15_CR223","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/01.CIR.19.1.7","volume":"19","author":"P Ruegsegger","year":"1959","unstructured":"Ruegsegger P, Nydick I, Hutter RC, Freiman AH, Bang NU, Cliffton EE, Ladue JS (1959) Fibrinolytic (plasmin) therapy of experimental coronary thrombi with alteration of the evolution of myocardial infarction. Circulation 19:7\u201313","journal-title":"Circulation"},{"key":"15_CR224","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1046\/j.1538-7836.2003.00441.x","volume":"1","author":"S Sadeghi","year":"2003","unstructured":"Sadeghi S, Marder VJ, Stewart D, Kong M, Humphries J, Baumbach GA, Jesmok G (2003) Safety of plasmin in the setting of concomitant aspirin and heparin administration in an animal model of bleeding. J Thromb Haemost 1:2621\u20132625","journal-title":"J Thromb Haemost"},{"key":"15_CR225","doi-asserted-by":"publisher","first-page":"27912","DOI":"10.1074\/jbc.271.44.27912","volume":"271","author":"DV Sakharov","year":"1996","unstructured":"Sakharov DV, Lijnen HR, Rijken DC (1996) Interactions between staphylokinase, plasmin (ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin. J Biol Chem 271:27912\u201327918","journal-title":"J Biol Chem"},{"key":"15_CR226","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1432-1033.1985.tb08961.x","volume":"149","author":"T Sako","year":"1985","unstructured":"Sako T (1985) Overproduction of staphylokinase in Escherichia coli and its characterization. Eur J Biochem 149:557\u2013563","journal-title":"Eur J Biochem"},{"key":"15_CR227","first-page":"173","volume-title":"Cardiovascular thrombosis: thrombocardiology","author":"M Samama","year":"1997","unstructured":"Samama M, Walenga J, Kaiser B, Fareed J (1997) Specific factor Xa inhibitors. In: Verstraete M, Fuster V, Topol E (eds) Cardiovascular thrombosis: thrombocardiology. Lippincott-Raven, Brussels, pp 173\u2013188"},{"key":"15_CR228","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/185624a0","volume":"185","author":"NK Sarkar","year":"1960","unstructured":"Sarkar NK (1960) Mechanism of clot lysis. Nature 185:624\u2013625","journal-title":"Nature"},{"key":"15_CR229","first-page":"540","volume":"38","author":"S Sasaki","year":"2000","unstructured":"Sasaki S, Kawanami R, Motizuki Y, Nakahara Y, Kawamura T, Tanaka A, Watanabe S (2000) Serrapeptase-induced lung injury manifesting as acute eosiniphilic pneumonia. Nihon Kokyuki Gakkai Zasshi 38:540\u2013544","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"15_CR230","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1172\/JCI102973","volume":"33","author":"S Sherry","year":"1954","unstructured":"Sherry S (1954) The fibrinolytic activity of streptokinase activated human plasmin. J Clin Invest 33:1054\u20131063","journal-title":"J Clin Invest"},{"key":"15_CR231","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/0002-8703(81)90643-8","volume":"102","author":"S Sherry","year":"1981","unstructured":"Sherry S (1981) Personal reflections on the development of thrombolytic therapy and its application to acute coronary thrombosis. Am Heart J 102:1134\u20131138","journal-title":"Am Heart J"},{"key":"15_CR232","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/clc.4960131303","volume":"13","author":"S Sherry","year":"1990","unstructured":"Sherry S (1990) Pharmacology of anistreplase. Clin Cardiol 13:3\u201310","journal-title":"Clin Cardiol"},{"key":"15_CR233","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/S10267-011-0179-3","volume":"53","author":"N Shirasaka","year":"2012","unstructured":"Shirasaka N, Naitou M, Okamura K, Fukuta Y, Terashita T, Kusuda M (2012) Purification and characterization of a fibrinolytic protease from Aspergillus oryzae KSK-3. Mycoscience 53:354\u2013364","journal-title":"Mycoscience"},{"key":"15_CR234","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11239-008-0290-2","volume":"28","author":"HV Shivaprasad","year":"2009","unstructured":"Shivaprasad HV, Riyaz M, Venkatesh Kumar R, Dharmappa KK, Tarannum S, Siddesha JM, Rajesh R, Vishwanath BS (2009) Cysteine proteases from the Asclepiadaceae plants latex exhibited thrombin and plasmin like activities. J Thromb Thrombolysis 28:304\u2013308","journal-title":"J Thromb Thrombolysis"},{"key":"15_CR235","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1538-7836.2008.02969.x","volume":"6","author":"RD Shlansky-Goldberg","year":"2008","unstructured":"Shlansky-Goldberg RD, Matsumoto AH, Baumbach GA, Siegel JB, Raabe RD, Murphy TP, Deng C, Ray Dawkins J, Marder VJ (2008) A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion. J Thromb Haemost 6:944\u2013950","journal-title":"J Thromb Haemost"},{"key":"15_CR236","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0304-4165(91)90156-B","volume":"1074","author":"E Siigur","year":"1991","unstructured":"Siigur E, Siigur J (1991) Purification and characterization of lebetase, a fibrinolytic enzyme from Vipera lebetina (snake) venom. Biochim Biophys Acta 1074:223\u2013229","journal-title":"Biochim Biophys Acta"},{"key":"15_CR237","first-page":"318","volume":"34","author":"N Sikri","year":"2007","unstructured":"Sikri N, Bardia A (2007) A history of streptokinase use in acute myocardial infarction. Tex Heart Inst J 34:318\u2013327","journal-title":"Tex Heart Inst J"},{"key":"15_CR238","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/1809-4392201600022","volume":"46","author":"GMM Silva","year":"2016","unstructured":"Silva GMM, Bezerra RP, Teixeira JA, Silva FO, Correia JM, Porto TS, Lima-Filho JL, Porto ALF (2016) Screening, production and biochemical characterization of a new fibrinolytic enzyme produced by Streptomyces sp. (Streptomycetaceae) isolated from Amazonian lichens. Acta Amazon 46:323\u2013332","journal-title":"Acta Amazon"},{"key":"15_CR239","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.procbio.2009.08.010","volume":"45","author":"JR Simkhada","year":"2010","unstructured":"Simkhada JR, Mander P, Cho SS, Yoo JC (2010) A novel fibrinolytic protease from Streptomyces sp. CS684. Process Biochem 45:88\u201393","journal-title":"Process Biochem"},{"key":"15_CR240","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bbapap.2012.05.002","volume":"1824","author":"J Siritapetawee","year":"2012","unstructured":"Siritapetawee J, Thumanu K, Sojikul P, Thammasirirak S (2012) A novel serine protease with human fibrino(geno)lytic activities from Artocarpus heterophyllus latex. Biochim Biophys Acta 1824:907\u2013912","journal-title":"Biochim Biophys Acta"},{"key":"15_CR241","first-page":"30","volume":"92","author":"J Siritapetawee","year":"2015","unstructured":"Siritapetawee J, Sojikul P, Klaynongsruang S (2015) Biochemical characterization of a new glycosylated protease from Euphorbia cf. lactea latex. Plant Physiol. Biochemist 92:30\u201338","journal-title":"Biochemist"},{"key":"15_CR242","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0002-9149(96)00736-9","volume":"78","author":"RW Smalling","year":"1996","unstructured":"Smalling RW (1996) Molecular biology of plasminogen activators: what are the clinical implications of drug design? The am. J Cardiol 78:2\u20137","journal-title":"J Cardiol"},{"key":"15_CR243","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/newbio231235a0","volume":"231","author":"JB Smith","year":"1971","unstructured":"Smith JB, Willis AL (1971) Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol 231:235","journal-title":"Nat New Biol"},{"key":"15_CR244","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/290505a0","volume":"290","author":"RA Smith","year":"1981","unstructured":"Smith RA, Dupe RJ, English PD, Green J (1981) Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapy. Nature 290:505\u2013508","journal-title":"Nature"},{"key":"15_CR245","first-page":"191","volume-title":"Progress in chemical fibrinolysis and thrombolysis","author":"L Sottrup-Jensen","year":"1978","unstructured":"Sottrup-Jensen L, Claeys H, Zajdel M, Petersen T, Magnusson S (1978) The primary structure of human plasminogen: isolation of two lysine binding fragments and one mini plasminogen (MW 38000) by elastase catalyzed specific limited proteolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis. Raven Press, New York, pp 191\u2013209"},{"key":"15_CR246","first-page":"929","volume":"170","author":"A Stage","year":"1952","unstructured":"Stage A, Astrup T (1952) Isolation of a soluble fibrinolytic activator from animal tissue. Nature 170:929","journal-title":"Nature"},{"key":"15_CR247","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0021-9258(18)51377-6","volume":"138","author":"MA Stahmann","year":"1941","unstructured":"Stahmann MA, Huebner CF, Link KP (1941) Studies on the hemorrhagic sweet clover disease: v. Identification and synthesis of the hemorrhagic agent. J Biol Chem 138:513\u2013527","journal-title":"J Biol Chem"},{"key":"15_CR248","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.2174\/0929867043364603","volume":"11","author":"JM Stassen","year":"2004","unstructured":"Stassen JM, Arnout J, Deckmyn H (2004) The hemostatic system. Curr Med Chem 11:2245\u20132260","journal-title":"Curr Med Chem"},{"key":"15_CR249","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/pro.5560010806","volume":"1","author":"J Sturzebecher","year":"1992","unstructured":"Sturzebecher J, Neumann U, Kohnert U, Kresse GB, Fischer S (1992) Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates. Protein Sci 1:1007\u20131013","journal-title":"Protein Sci"},{"key":"15_CR250","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/BF01956052","volume":"43","author":"H Sumi","year":"1987","unstructured":"Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H (1987) A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia 43:1110\u20131111","journal-title":"Experientia"},{"key":"15_CR251","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000205051","volume":"84","author":"H Sumi","year":"1990","unstructured":"Sumi H, Hamada H, Nakanishi K, Hiratani H (1990) Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol 84:139\u2013143","journal-title":"Acta Haematol"},{"key":"15_CR252","first-page":"479","volume":"46","author":"AL Sun","year":"1998","unstructured":"Sun AL, Hua ZC, Yao J, Yang YH, Yin DQ (1998) Fusion expression of human pro-urokinase with E. coli thioredoxin. Biochem Mol Biol Int 46:479\u2013486","journal-title":"Biochem Mol Biol Int"},{"key":"15_CR253","first-page":"721","volume":"5","author":"YY Sung","year":"2012","unstructured":"Sung YY, Yang WK, Kim HK (2012) Antiplatelet, anticoagulant and fibrinolytic effects of Litchi chinensis Sonn. extract. Mol Med Rep 5:721\u2013724","journal-title":"Mol Med Rep"},{"key":"15_CR05","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00005344-199105000-00008","volume":"17","author":"S Suzuki","year":"1991","unstructured":"Suzuki S, Saito M, Suzuki N, Kato H, Nagaoka N, Yoshitake S, Mizuo H, Yuzuriha T, Yui Y, Kawai C (1991) Thrombolytic properties of a novel modified human tissue-type plasminogen activator (E6010): a bolus injection of E6010 has equivalent potency of lysing young and aged canine coronary thrombi. J Cardiovasc Pharmacol 17:738\u2013746","journal-title":"J Cardiovasc Pharmacol"},{"key":"15_CR254","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/j.1538-7836.2004.00889.x","volume":"2","author":"Y Suzuki","year":"2004","unstructured":"Suzuki Y, Nagai N, Collen D (2004) Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in mice. J Thromb Haemost 2:1617\u20131621","journal-title":"J Thromb Haemost"},{"key":"15_CR255","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/j.1538-7836.2005.01480.x","volume":"3","author":"J Szemraj","year":"2005","unstructured":"Szemraj J, Walkowiak B, Kawecka I, Janiszewska G, Buczko W, Bartkowiak J, Chabielska E (2005) A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity-a staphylokinase variant. I. In vitro study. J Thromb Haemost 3:2156\u20132165","journal-title":"J Thromb Haemost"},{"key":"15_CR256","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S1734-1140(11)70636-3","volume":"63","author":"J Szemraj","year":"2011","unstructured":"Szemraj J, Zakrzeska A, Brown G, Stankiewicz A, Gromotowicz A, Gr\u0119dzinski T, Chabielska E (2011) New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats. Pharmacol Rep 63:1169\u20131179","journal-title":"Pharmacol Rep"},{"key":"15_CR257","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s13205-017-0808-4","volume":"7","author":"K Taneja","year":"2017","unstructured":"Taneja K, Bajaj BK, Kumar S, Dilbaghi N (2017) Production, purification and characterization of fibrinolytic enzyme from Serratia sp. KG-2-1 using optimized media. 3 Biotech 7:184","journal-title":"3 Biotech"},{"key":"15_CR258","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1023\/A:1018352328874","volume":"19","author":"S Tao","year":"1997","unstructured":"Tao S, Peng L, Beihui L, Deming L, Zuohu L (1997) Solid state fermentation of rice chaff for fibrinolytic enzyme production by Fusarium oxysporum. Biotechnol Lett 19:465\u2013467","journal-title":"Biotechnol Lett"},{"key":"15_CR259","first-page":"379","volume":"18","author":"S Tao","year":"1998","unstructured":"Tao S, Peng L, Beihui L, Deming L, Zuohu L (1998) Successive cultivation of Fusarium oxysporum on rice chaff for economic production of fibrinolytic enzyme. Bioprocess Eng 18:379\u2013381","journal-title":"Bioprocess Eng"},{"key":"15_CR260","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0735-1097(97)00553-6","volume":"31","author":"U Tebbe","year":"1998","unstructured":"Tebbe U, Michels R, Adgey J, Boland J, Caspi A, Charbonnier B, Windeler J, Barth H, Groves R, Hopkins GR, Fennell W, Betriu A, Ruda M, Mlczoch J (1998) Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS equivalence trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators. J Am Coll Cardiol 31:487\u2013493","journal-title":"J Am Coll Cardiol"},{"key":"15_CR261","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3923\/biotech.2006.160.165","volume":"5","author":"N Tharwat","year":"2006","unstructured":"Tharwat N (2006) Purification and biochemical characterization of fibrinolytic enzyme produced by thermophilic fungus Oidiodendron flavum. Biotechnology 5:160\u2013165","journal-title":"Biotechnology"},{"key":"15_CR262","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1161\/STROKEAHA.109.560201","volume":"40","author":"VNS Thijs","year":"2009","unstructured":"Thijs VNS, Peeters A, Vosko M, Aichner F, Schellinger PD, Schneider D, Neumann-Haefelin T, Rother J, Davalos A, Wahlgren N, Verhamme P (2009) Randomized, placebo-controlled, dose-ranging clinical trial of intravenous microplasmin in patients with acute ischemic stroke. Stroke 40:3789\u20133795","journal-title":"Stroke"},{"key":"15_CR263","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1084\/jem.58.4.485","volume":"58","author":"WS Tillett","year":"1933","unstructured":"Tillett WS, Garner RL (1933) The fibrinolytic activity of hemolytic Streptococci. J Exp Med 58:485\u2013502","journal-title":"J Exp Med"},{"key":"15_CR264","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1172\/JCI102046","volume":"28","author":"WS Tillett","year":"1949","unstructured":"Tillett WS, Sherry S (1949) The effect in patients of streptococcal fibrinolysin (streptokinase) and streptococcal desoxyribonuclease on fibrinous, purulent, and sanguinous pleural exudations. J Clin Invest 28:173\u2013190","journal-title":"J Clin Invest"},{"key":"15_CR265","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1055\/s-0035-1569406","volume":"66","author":"RR Tjandrawinata","year":"2016","unstructured":"Tjandrawinata RR, Yunaidi DA, Susanto LW (2016) The safety and tolerability of lumbrokinase DLBS1033 in healthy adult subjects. Drug Res (Stuttg) 66:293\u2013299","journal-title":"Drug Res (Stuttg)"},{"key":"15_CR266","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7748\/ns.19.37.55.s54","volume":"19","author":"J Tough","year":"2005","unstructured":"Tough J (2005) Thrombolytic therapy in acute myocardial infarction. Nurs Stand 19:55\u201364","journal-title":"Nurs Stand"},{"key":"15_CR267","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/j.1538-7836.2005.01602.x","volume":"3","author":"AGG Turpie","year":"2005","unstructured":"Turpie AGG, Fisher WD, Bauer KA, Kwong LM, Irwin MW, Kalebo P, Misselwitz F, Gent M, OdiXa-Knee Study Group (2005) BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study. J Thromb Haemost 3:2479\u20132486","journal-title":"J Thromb Haemost"},{"key":"15_CR268","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00253-006-0621-1","volume":"74","author":"M Ueda","year":"2007","unstructured":"Ueda M, Kubo T, Miyatake K, Nakamura T (2007) Purification and characterization of fibrinolytic alkaline protease from Fusarium sp. BLB Appl Microbiol Biotechnol 74:331","journal-title":"BLB Appl Microbiol Biotechnol"},{"key":"15_CR269","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.enzmictec.2010.08.003","volume":"48","author":"Y Uesugi","year":"2011","unstructured":"Uesugi Y, Usuki H, Iwabuchi M, Hatanaka T (2011) Highly potent fibrinolytic serine protease from Streptomyces. Enzym Microb Technol 48:7\u201312","journal-title":"Enzym Microb Technol"},{"key":"15_CR270","doi-asserted-by":"publisher","first-page":"24690","DOI":"10.1074\/jbc.M101751200","volume":"276","author":"T Urano","year":"2001","unstructured":"Urano T, Ihara H, Umemura K, Suzuki Y, Oike M, Akita S, Tsukamoto Y, Suzuki I, Takada A (2001) The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor type 1. J Biol Chem 276:24690\u201324696","journal-title":"J Biol Chem"},{"key":"15_CR271","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0140-6736(99)07403-6","volume":"354","author":"F Van De Werf","year":"1999","unstructured":"Van De Werf F, Adgey J, Ardissino D, Armstrong PW, Aylward P, Barbash G, Betriu A, Binbrek AS, Califf R, Diaz R, Fanebust R, Fox K, Granger C, Heikkila J, Husted S, Jansky P, Langer A, Lupi E, Maseri A, Meyer J, Mlczoch J, Mocceti D, Myburgh D, Oto A, Paolasso E, Pehrsson K, Seabra-Gomes R, Soares-Piegas L, S\u00f9grue D, Tendera M, Topol E, Toutouzas P, Vahanian A, Verheugt F, Wallentin L, White H (1999a) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 354:716\u2013722","journal-title":"Lancet"},{"key":"15_CR272","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0002-8703(99)70400-X","volume":"137","author":"F Van de Werf","year":"1999","unstructured":"Van de Werf F, Cannon CP, Luyten A, Houbracken K, McCabe CH, Berioli S, Bluhmki E, Sarelin H, Wang-Clow F, Fox NL, Braunwald E (1999b) Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J 137:786\u2013791","journal-title":"Am Heart J"},{"key":"15_CR273","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jcb.240320302","volume":"32","author":"AJ van Zonneveld","year":"1986","unstructured":"van Zonneveld AJ, Veerman H, MacDonald ME, van Mourik JA, Pannekoek H (1986) Structure and function of human tissue-type plasminogen activator (t-PA). J Cell Biochem 32:169\u2013178","journal-title":"J Cell Biochem"},{"key":"15_CR274","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1161\/01.CIR.92.8.2044","volume":"92","author":"S Vanderschueren","year":"1995","unstructured":"Vanderschueren S, Barrios L, Kerdsinchai P, Van den Heuvel P, Hermans L, Vrolix M, De Man F, Benit E, Muyldermans L, Collen D (1995a) A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group. Circulation 92:2044\u20132049","journal-title":"Circulation"},{"key":"15_CR275","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/01.CIR.92.8.2050","volume":"92","author":"S Vanderschueren","year":"1995","unstructured":"Vanderschueren S, Stockx L, Wilms G, Lacroix H, Verhaeghe R, Vermylen J, Collen D (1995b) Thrombolytic therapy of peripheral arterial occlusion with recombinant staphylokinase. Circulation 92:2050\u20132057","journal-title":"Circulation"},{"key":"15_CR276","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1055\/s-0038-1650619","volume":"76","author":"S Vanderschueren","year":"1996","unstructured":"Vanderschueren S, Collen D, van de Werf F (1996) A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis. Thromb Haemost 76:541\u2013544","journal-title":"Thromb Haemost"},{"key":"15_CR277","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0002-8703(97)70127-3","volume":"134","author":"S Vanderschueren","year":"1997","unstructured":"Vanderschueren S, Dens J, Kerdsinchai P, Desmet W, Vrolix M, De Man F, Van den Heuvel P, Hermans L, Collen D, Van de Werf F (1997) Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction. Am Heart J 134:213\u2013219","journal-title":"Am Heart J"},{"key":"15_CR278","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232\u2013235","journal-title":"Nat New Biol"},{"key":"15_CR279","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0002-9343(00)00380-6","volume":"109","author":"M Verstraete","year":"2000","unstructured":"Verstraete M (2000) Third-generation thrombolytic drugs. Am J Med 109:52\u201358","journal-title":"Am J Med"},{"key":"15_CR280","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/MBC.0b013e32835d540b","volume":"24","author":"CA Viana","year":"2013","unstructured":"Viana CA, Oliveira JS, Freitas CDT, Alencar NMN, Carvalho CPS, Nishi BC, Ramos MV (2013) Thrombin and plasmin-like activities in the latices of Cryptostegia grandiflora and Plumeria rubra. Blood Coagul Fibrinolysis 24:386\u2013392","journal-title":"Blood Coagul Fibrinolysis"},{"key":"15_CR281","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/725064","volume":"2014","author":"P Vijayaraghavan","year":"2014","unstructured":"Vijayaraghavan P, Vincent SGP (2014) Statistical optimization of fibrinolytic enzyme production using agroresidues by Bacillus cereus IND1 and its thrombolytic activity in vitro. Biomed Res Int 2014:725064","journal-title":"Biomed Res Int"},{"key":"15_CR282","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.btre.2015.06.005","volume":"7","author":"P Vijayaraghavan","year":"2015","unstructured":"Vijayaraghavan P, Vincent SGP (2015) A low cost fermentation medium for potential fibrinolytic enzyme production by a newly isolated marine bacterium, Shewanella sp. IND20. Biotechnol Rep 7:135\u2013142","journal-title":"Biotechnol Rep"},{"key":"15_CR283","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3923\/ijbc.2015.11.20","volume":"9","author":"P Vijayaraghavan","year":"2015","unstructured":"Vijayaraghavan P, Raj F, Vincent SGP (2015) Purification and characterization of fibrinolytic enzyme from Pseudoalteromonas sp. IND11 and its in vitro activity on blood clot. Int J Biol Chem 9:11\u201320","journal-title":"Int J Biol Chem"},{"key":"15_CR284","doi-asserted-by":"publisher","first-page":"434","DOI":"10.22205\/sijbs\/2016\/v2\/i4\/103450","volume":"2","author":"P Vijayaraghavan","year":"2016","unstructured":"Vijayaraghavan P, Vincent SGP, Arasu MV (2016a) Purification, characterization of a novel fibrinolytic enzyme from Paenibacillus sp. IND8, and its in vitro thrombolytic activity. SIJBS 2:434\u2013444","journal-title":"SIJBS"},{"key":"15_CR285","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejbt.2016.01.002","volume":"20","author":"P Vijayaraghavan","year":"2016","unstructured":"Vijayaraghavan P, Vincent SGP, Arasu MV, Al-Dhabi NA (2016b) Bioconversion of agro-industrial wastes for the production of fibrinolytic enzyme from Bacillus halodurans IND18: purification and biochemical characterization. Electron J Biotechnol 20:1\u20138","journal-title":"Electron J Biotechnol"},{"key":"15_CR286","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1016\/S0021-9258(17)33334-3","volume":"251","author":"BN Violand","year":"1976","unstructured":"Violand BN, Castellino FJ (1976) Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem 251:3906\u20133912","journal-title":"J Biol Chem"},{"key":"15_CR287","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1161\/STROKEAHA.116.013715","volume":"47","author":"R von Kummer","year":"2016","unstructured":"von Kummer R, Mori E, Truelsen T, Jensen JKS, Gronning BA, Fiebach JB, Lovblad KO, Pedraza S, Romero JM, Chabriat H, Chang KC, Davalos A, Ford GA, Grotta J, Kaste M, Schwamm LH, Shuaib A, Albers GW (2016) Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 trial (efficacy and safety study of desmoteplase to treat acute ischemic stroke). Stroke 47:2880\u20132887","journal-title":"Stroke"},{"key":"15_CR288","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1517\/13543784.11.3.397","volume":"11","author":"JM Walenga","year":"2002","unstructured":"Walenga JM, Jeske WP, Samama MM, Frapaise FX, Bick RL, Fareed J (2002) Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent. Expert Opin Investig Drugs 11:397\u2013407","journal-title":"Expert Opin Investig Drugs"},{"key":"15_CR289","first-page":"83","volume":"15","author":"J Wang","year":"1999","unstructured":"Wang J, Wang M, Wang Y (1999) Purification and characterization of a novel fibrinolytic enzyme from Streptomyces spp. Chin J Biotechnol 15:83\u201389","journal-title":"Chin J Biotechnol"},{"key":"15_CR290","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1023\/A:1024196232252","volume":"25","author":"F Wang","year":"2003","unstructured":"Wang F, Wang C, Li M, Gui L, Zhang J, Chang W (2003) Purification, characterization and crystallization of a group of earthworm fibrinolytic enzymes from Eisenia fetida. Biotechnol Lett 25:1105\u20131109","journal-title":"Biotechnol Lett"},{"key":"15_CR291","doi-asserted-by":"publisher","first-page":"9722","DOI":"10.1021\/jf901861v","volume":"57","author":"C Wang","year":"2009","unstructured":"Wang C, Du M, Zheng D, Kong F, Zu G, Feng Y (2009a) Purification and characterization of nattokinase from Bacillus subtilis natto B-12. J Agric Food Chem 57:9722\u20139729","journal-title":"J Agric Food Chem"},{"key":"15_CR292","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.procbio.2008.09.009","volume":"44","author":"SL Wang","year":"2009","unstructured":"Wang SL, Chen HJ, Liang TW, Lin YD (2009b) A novel nattokinase produced by Pseudomonas sp. TKU015 using shrimp shells as substrate. Process Biochem 44:70\u201376","journal-title":"Process Biochem"},{"key":"15_CR293","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0140-6736(67)91658-3","volume":"2","author":"HJ Weiss","year":"1967","unstructured":"Weiss HJ, Aledort LM (1967) Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet 2:495\u2013497","journal-title":"Lancet"},{"key":"15_CR294","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ijms18030523","volume":"18","author":"Y Weng","year":"2017","unstructured":"Weng Y, Yao J, Sparks S, Wang KY (2017) Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease. Int J Mol Sci 18:523","journal-title":"Int J Mol Sci"},{"key":"15_CR295","unstructured":"WHO (2017) World Health Organization fact sheet fs317 cardiovascular diseases (CVDs) updated May 2017"},{"key":"15_CR296","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1432-1033.1977.tb11578.x","volume":"76","author":"B Wiman","year":"1977","unstructured":"Wiman B (1977) Primary structure of the B-chain of human plasmin. Eur J Biochem 76:129\u2013137","journal-title":"Eur J Biochem"},{"key":"15_CR07","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0049-3848(77)90003-2","volume":"10","author":"B Wiman","year":"1977","unstructured":"Wiman B, Wallen P (1977) The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb Res 10:213\u2013222","journal-title":"Thromb Res"},{"key":"15_CR297","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1432-1033.1978.tb12360.x","volume":"87","author":"B Wiman","year":"1978","unstructured":"Wiman B, Boman L, Collen D (1978) On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin. Eur J Biochem 87:143\u2013146","journal-title":"Eur J Biochem"},{"key":"15_CR298","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0005-2795(79)90094-1","volume":"579","author":"B Wiman","year":"1979","unstructured":"Wiman B, Lijnen HR, Collen D (1979) On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen. Biochim Biophys Acta 579:142\u2013154","journal-title":"Biochim Biophys Acta"},{"key":"15_CR299","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1128\/aem.60.2.517-523.1994","volume":"60","author":"SL Wong","year":"1994","unstructured":"Wong SL, Ye R, Nathoo S (1994) Engineering and production of streptokinase in a Bacillus subtilis expression-secretion system. Appl Environ Microbiol 60:517\u2013523","journal-title":"Appl Environ Microbiol"},{"key":"15_CR08","doi-asserted-by":"publisher","first-page":"8793","DOI":"10.1073\/pnas.84.24.8793","volume":"84","author":"HL Wu","year":"1987","unstructured":"Wu HL, Shi GY, Wohl RC, Bender ML (1987) Structure and formation of microplasmin. Proc Natl Acad Sci U S A 84:8793\u20138795","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR300","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001721-199404000-00001","volume":"5","author":"TP Wu","year":"1994","unstructured":"Wu TP, Padmanabhan KP, Tulinsky A (1994) The structure of recombinant plasminogen kringle 1 and the fibrin binding site. Blood Coagul Fibrinolysis 5:157\u2013166","journal-title":"Blood Coagul Fibrinolysis"},{"key":"15_CR301","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10295-008-0516-5","volume":"36","author":"B Wu","year":"2009","unstructured":"Wu B, Wu L, Chen D, Yang Z, Luo M (2009) Purification and characterization of a novel fibrinolytic protease from Fusarium sp. CPCC 480097. J Ind Microbiol Biotechnol 36:451\u2013459","journal-title":"J Ind Microbiol Biotechnol"},{"key":"15_CR302","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijbiomac.2016.08.041","volume":"93","author":"D Wu","year":"2016","unstructured":"Wu D, Li P, Zhou J, Gao M, Lou X, Ran T, Wu S, Wang W, Xu D (2016) Identification of a toxic serralysin family protease with unique thermostable property from S. marcescens FS14. Int J Biol Macromol 93:98\u2013106","journal-title":"Int J Biol Macromol"},{"key":"15_CR303","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00253-004-1846-5","volume":"67","author":"L Xiao-lan","year":"2005","unstructured":"Xiao-lan L, Lian-xiang D, Fu-ping L, Xi-qun Z, Jing X (2005) Purification and characterization of a novel fibrinolytic enzyme from Rhizopus chinensis 12. Appl Microbiol Biotechnol 67:209\u2013214","journal-title":"Appl Microbiol Biotechnol"},{"key":"15_CR304","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4196\/kjpp.2010.14.2.71","volume":"14","author":"XM Yan","year":"2010","unstructured":"Yan XM, Kim CH, Lee CK, Shin JS, Cho IH, Sohn UD (2010) Intestinal absorption of fibrinolytic and proteolytic lumbrokinase extracted from earthworm, Eisenia andrei. Korean J Physiol Pharmacol 14:71\u201375","journal-title":"Korean J Physiol Pharmacol"},{"key":"15_CR305","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bej.2007.09.016","volume":"39","author":"M Yokota","year":"2008","unstructured":"Yokota M, Tanji Y (2008) Analysis of cell-cycle-dependent production of tissue plasminogen activator analogue (pamiteplase) by CHO cells. Biochem Eng J 39:297\u2013304","journal-title":"Biochem Eng J"},{"key":"15_CR306","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-0038-1661127","volume":"52","author":"C Zamarron","year":"1984","unstructured":"Zamarron C, Lijnen HR, Van Hoef B, Collen D (1984) Biological and thrombolytic properties of proenzyme and active forms of human urokinase-I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb Haemost 52:19\u201323","journal-title":"Thromb Haemost"},{"key":"15_CR307","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00001573-199909000-00007","volume":"14","author":"U Zeymer","year":"1999","unstructured":"Zeymer U, Neuhaus KL (1999) Clinical trials in acute myocardial infarction. Curr Opin Cardiol 14:392","journal-title":"Curr Opin Cardiol"}],"container-title":["Advances in Experimental Medicine and Biology","Therapeutic Enzymes: Function and Clinical Implications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-7709-9_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:35:18Z","timestamp":1721687718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-13-7709-9_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811377082","9789811377099"],"references-count":315,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-7709-9_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"4 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}